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Abstract
The cysteine proteinases, cathepsins LI (SmCLl) and L2 (SmCL2) from the parasitic 
helminth Schistosoma mansoni were functionally expressed in Saccharomyces cerevisiae. 
By transforming the yeast with cDNAs encoding the complete pre-pro-enzymes, the 
recombinant proteinases were secreted into the culture medium from which they were 
purified by gel filtration and/or anion exchange chromatography. The enzymes were 
secreted by the yeast cells in their mature, active form and demonstrated characteristics 
typical of cathepsin L-like cysteine proteinases. Proteins in the purified fractions were 
reactive with anti-sera prepared against the recombinant enzymes which had been 
expressed in, and purified from extracts of Escherichia coli.
Yeast-expressed SmCLl and SmCL2 displayed distinct differences in their specificities for 
synthetic peptide substrates; SmCLl favours substrates containing aliphatic (P3)-aliphatic 
(P2)-positive or polar hydrophobic (Pi) residues, whereas SmCL2 showing a preference 
for aliphatic (P3)-aromatic (P2)-positive (Pi). SmCLl cleaved a broader range of 
substrates tested and was also active over a wider pH range than SmCL2. SmCLl showed 
a pH optimum of 6.5 for activity against Z-Phe-Arg-NHMec, while SmCL2 was optimally 
active at pH 5.5 against this substrate. RT-PCR and immunoblotting studies revealed 
expression profiles of these proteinases also differed in the various life cycle stages of S. 
mansoni; both proteinases are expressed in male and female adults but at different levels, 
and the pro-form of SmCLl is also expressed in cercariae.
Immunolocalisation experiments demonstrated that SmCLl was expressed in the 
gastrodermal cells lining the schistosome gut, as well as in the tegument of adult worms. 
Immunoblotting studies which detected the presence of SmCLl in the excretory/secretory 
products of adult worms suggests that this enzyme is secreted by the parasite. Moreover, 
recombinant yeast-expressed SmCLl had a marked preference for haemoglobin as 
substrate. Collectively, these results suggest that SmCLl plays some role in the 
degradation of host haemoglobin in the schistosome gut.
SmCL2 has been localised to the reproductive organs of adult schistosomes by another 
laboratory and has been implicated to be involved in egg formation in female parasites. 
Therefore, SmCLl and SmCL2 perform different functions in schistosomes. Both these 
enzymes now represent novel targets at which chemotherapy and/or immunoprophylaxis 
may be directed.
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Abbreviations
ADH Alcohol dehydrogenase
AEBSF 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride
AFC Aminofluoromethylcourmarin
BCIP 5 -bromo-5 -chloro-3 -indolyl phosphate
Boc t-butyloxycarbonyl
BSA Bovine serum albumin
bSmCLl Bacterially-expressed recombinant SmCLl
bSmCL2 BacteriaUy-expressed recombinant SmCL2
cDNA Complementary DNA
c h n 2 diazomethylketone
DEAE diethylaminoethyl
DFP Diisopropylphosphofluoridate
DIG Digoxygenin
DPP I Dipeptidylpeptidase
DTT dithiothreitol
EC Enzyme classification
EDTA Ethylenediaminetetraacetic acid
ES products Excretory/secretoiy products
FITC Fluorescein isothiocyanate
Hb Haemoglobin
HIV Human Immunodeficiency Virus
IL Interleukin
IPTG Isopropylthio-P-D-galactoside
c^at First order rate constant (turnover number)
Km Michelis-Menten constant
LAP Leucine aminopeptidase
LB Luria Bertani medium
M6P Mannose-6-phosphate
NBT Nitroblue tetrazolium
NHMec Aminomethylcourmarin
NK Natural killer
PAGE Polyacrylamide gel electrophoresis
PBS Phosphate buffered saline
PCR Polymerase chain reaction
pi Isoelectric point
QAE Quaternary aminoethyl
RBC Red blood cells
RPMI Roswell Park Memorial Institute
SDS Sodium dodecyl sulphate
SmCLl S. mcmsoni cathepsin LI
SmCL2 S. mcmsoni cathepsin L2
Sue Succinyl
TH T helper cell
TIMP Tissue inhibitor of metalloproteinases
Tos Tosyl
TPI Triose phosphate isomerase
Tris Tris-(hydroxy-methyl)-methylamine(2-amino hydroxymetyl)
propane-1,3-diol 
WE Adult schistosome worm extract
X-Gal l,5-bromo-4-chloro-3-indoyl-ß-D-galactosidae
ySmCLl Yeast-expressed recombinant SmCLl
ySmCL2 Yeast-expressed recombinant SmCL2
Z Benzoyl
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Chapter 1
Introduction
1.1 : Helminth parasites
Parasitic infections can be generally divided into two groups; those caused by protozoa 
and those caused by helminths. Protozoa are unicellular, they multiply within the definitive 
host, and are frequently intracellular in habitat. Helminths, as defined by Anderson and 
May (1979) are, on the other hand, “macroparasites which tend to have much longer 
generation times than the protozoans. Direct multiplication within the host is either absent 
or occurs at a very low rate. The immune responses elicited by helminths generally depend 
on the number of parasites present in a given host, and tend to be of relatively short 
duration. These infections, therefore, tend to be of persistent nature with hosts being 
continually reinfected.”
The study of helminths is regarded as the study of parasitic worms. Helminths 
typically parasitise vertebrates, although invertebrates act as intermediate hosts. The 
helminth diseases in man and domestic animals are caused by three groups of parasites 
belonging to the classes of trematoda (flatworms), nematoda (roundworms) and cestoda 
(tapeworms). Only a small proportion of individuals harbouring helminth infections, 
generally those individuals with heavy infection, are likely to develop overt disease. There 
is a low mortality/high morbidity rate associated with helminth infections. It is estimated 
that one quarter of the worlds population is infected with helminth parasites (Bundy, 
1992), and about 150,000 die each year as a result of these infections (Bundy et a l,
1990).
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1.2 : Schistosomiasis
Schistosomes, or blood flukes, are digenetic trematodes and are the causative agent of the 
parasitic disease schistosomiasis. Schistosomiasis, also known as Bilharzia, afflicts more 
than 250 million people in tropical regions of Central Africa, the Middle East, Eastern and 
South-East Asia, the Caribbean and in parts of South America, and more than 600 million 
are at risk of infection (World Health Organisation, 1996). It is estimated that 5-10% of 
heavily infected people will eventually die of their infection which accumulates to 
approximately 80,000 deaths per annum (Butterworth, 1989).
There are three common species which infect man, namely Schistosoma mansoni, 
Schistosoma japonicum and Schistosoma haematobium. The life cycle of Schistosoma 
mansoni is illustrated in Fig. 1.1. Eggs (Fig. 1.1, stage 1) that are passed in faeces of the 
primaiy host hatch into miracidiae in aggregations of water. The miracidiae (Fig. 1.1, 
stage 2) penetrate an intermediate host, the fresh water snail. In the snails, they develop 
two generations of sporocysts (Fig. 1.1, stages 3 A and 3B), the second of which produces 
fork-tailed cercariae (Fig. 1.1, stage 4). These cercariae penetrate the skin (Fig. 1.1, stage 
5) of the primary host when the host comes in contact with contaminated water. Once 
through the skin, the cercariae shed their tails and become schistosomulae which migrate 
through the tissues until they reach the portal venous system of the liver. Here, males and 
females (Fig. 1.1, stage 6) copulate before settling down in pairs in the mesenteric veins of 
the bowel or portal venous system of the liver. Adult females release numerous eggs each 
day and can do so for many years. The eggs move through the intestinal wall and are 
liberated into the lumen of the bowel, from which they reach the exterior.
Eggs are also carried with the circulation and are deposited in various body 
organs, particularly in the liver. The hosts inflammatory response to the eggs causes the 
tissue pathology associated with schistosomiasis (Mahmoud and Wahals, 1990). Eggs 
trapped in the liver elicit the development of an intense, cell-mediated granulomatous 
reaction which, with its associated fibrosis, is responsible for the clinical manifestations of 
portal hypertension and, in severe cases, rupture of the spleen and liver.
Fig 1.1 : Life cycle of Schistosoma mansoni. (Adapted from Peters and Gilles, 1995)
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Traditionally, the control of schistosomiasis has concentrated on improvements in hygiene, 
removal of the intermediate host and chemotherapy using broad range drugs such as 
praziquantal. Praziquantal is, however, expensive and patients become reinfected in areas 
of high transmission and re-treatment must therefore be carried out frequently and for an 
indefinite period. Also, resistance to praziquantal has been reported (Brindley 1994a, 
1994b) and it seems that resistant strains of the parasite are beginning to emerge. 
Resistance to praziquantel treatment has been induced in laboratory mice infected with S. 
mansoni (Brindley, 1994b).
Such drug resistance problems mean that the search for new strategies to control 
or eradicate schistosomiasis are essential. The successful eradication of schistosomiasis 
would involve the development of more effective and economically viable drugs, 
combined with an effective immunisation program designed to enhance host resistance to 
reinfection. Drugs with new modes of action and minimal toxicity to the host, as well as an 
effective vaccine, have still to be developed. The advent of recombinant DINA technology 
has opened up new opportunities in the identification of potential target molecules to 
which novel anti-schistosome chemotherapy and/or immunoprophylaxis could be directed.
1.3 : Proteinases
Proteinases are a complex group of enzymes that cleave peptide bonds. They display 
enormous variety in their physico-chemical and catalytic properties. Proteolytic enzymes 
are separated into two major groups - exopeptidases and endoproteinases. Exopeptidases 
remove one or more terminal amino acids from proteins and are further subdivided
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according to whether they act at the amino (aminopeptidases, dipeptidylpeptidases, 
tripeptidylpeptidases, etc.) or the carboxyl terminus (carboxypeptidases). Endoproteinases 
cleave internal peptide bonds in polypeptide substrates and are classified into four major 
groups on the basis of their active sites, mechanism of peptide bond cleavage, and three- 
dimensional structure. These are serine-, cysteine-, aspartic- and metallo-proteinases.
1.3.1 : Endoproteinase groups
The serine proteinase group (EC 3.4.21) consists of two distinct families : the mammalian 
serine proteinases (e.g. chymotrypsin (EC 3.4.21.1), trypsin (EC 3.4.21.4) and elastase 
(EC 3.4.21.11)) and the bacterial serine proteinases (e.g. subtilisin (EC 3.4.21.14)). Serine 
proteinases contain an essential serine residue at the catalytic site and are characterized by 
the catalytic triad of His 57, Asp 102 and Ser 195 (chymotypsin numbering). Differences 
in substrate specificity are determined by changes within the Si subsite of the active site.
The cysteine proteinase group includes the plant proteinase papain (EC 3.4.22.2) 
and the cytosolic calcium-activated calpains (EC 3.4.22.17). In the case of papain, the 
thiol group of Cys 25 and the side chains of His 159 and Asn 175 are essential for the 
catalytic process. In contrast to the serine proteinases, cysteine proteinases require 
reducing agents to stabilise or enhance their activity. The lysosomal cathepsins, including 
cathepsins B, H and L belong to the papain family of cysteine proteinases. They are 
probably the most active cellular proteinases and have a wide specificity for peptide bonds 
(Bond and Butler, 1987). The substrate specificity of the different cathepsins is determined 
by interactions between the S2 subsite and the substrate P2 residue.
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The aspartic proteinase group includes pepsin (EC 3.4.23.1), renin (EC 3.4.99.19), 
lysosomal cathepsin D (EC 3.4.23.5) and human immunodeficiency virus (HIV) 
proteinase. The aspartic proteinases are characterised by having maximal activity at low 
pH values. The catalytic process of these proteinases involves two aspartic residues in 
close proximity to each other in the centre of the substrate binding cleft. The substrate 
specificity of aspartic proteinases is extremely diverse (Neurath, 1990).
Metalloproteinases generally maintain optimum activity in the neutral pH range 
and contain a metal ion, usually zinc, which serves as a catalyst for hydrolysis. Removal of 
the metal ion by chelators inactivates these enzymes. This group contains the mammalian 
matrix metalloproteinases (collagenases and gelatinases) and bacterial thermolysin.
1.3.2 : Proteinase inhibitors
Many natural protein inhibitors of proteinases have been discovered and characterised 
including the serpins (serine proteinase inhibitors) , cystatins (cysteine proteinases) and 
TEMP (tissue inhibitor of metalloproteinases). Synthetic inhibitors are readily available 
which can be used to distinguish the group to which the proteinase under study belongs. 
The organophosphate diisopropylphosphofluoridate (DFP) and 4-(2-aminoethyl)- 
benzenesulfonyl fluoride hydrochloride (AEBSF) are commonly used inhibitors of serine 
proteinases. Pepstatin A, a pentapeptide-like compound, is routinely used to identify 
aspartic proteinases. Various metal chelators, including ethylenediaminetetraacetic acid 
(EDTA) and 1,10 phenathroline, which has a high affinity for zinc, are used to characterise 
metalloproteinases. The peptide epoxide L-/ram-epoxysuccinyl-leucylamido(4- 
guanidino)butane (E-64) is a potent, irreversible inhibitor of cysteine proteinases. Specific
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synthetic peptide inhibitors are also available which can be used to distinguish between 
sub-classes of proteinases. Examples of these include Benzoyl(Z)-Phe-Ala- 
diazometylketone(CHN2) and Z-Phe-Phe-CHN2 , which are specific, irreversible inhibitors 
of cathepsin Ls and Bs (Salvesen and Nagase, 1990).
1.4 : Proteinases of parasitic helminths
Proteinases can play many roles in host-parasite interactions. It is clear from examination 
of the life cycle of helminth parasites that proteinases perform key functions in their 
development. Several proteinases are elaborated at different stages of the life cycle to 
perform functions such as facilitating tissue invasion, evading the host immune response, 
triggering or contributing to morphological changes and allowing metabolism within the 
host.
Proteolytic enzymes must have originated very early in evolution, since all 
organisms require them for digestion and metabolism of their own proteins. In the early 
days of life, a limited set of peptidases with a broad substrate specificity, could have 
accounted for this activity (Jensen, 1976). It is reasonable to assume that from this limited 
set of ancestral enzymes a complex series of proteinases evolved by a process of gene 
duplication and divergence. Subsequent to this divergence, the enzymes would have 
acquired a higher degree of specificity by tailoring their catalysis to a discrete suite of 
peptide bonds located at specific sites in protein substrates. At the same time, the 
expression and distribution of these new proteinases could also be restricted, generating 
specialised proteinases for specific purposes (Neurath, 1984; Creighton and Darby, 1989).
This diversification of proteinases has undoubtedly contributed to the success of 
parasitic helminths. The main selection pressure that initiated the parasite-host relationship 
may have been the ease by which nutrients could be acquired from the host by the parasite 
(Halton, 1997) and hence it is found that much of the predominant proteolytic activity in 
helminth parasites are involved in this function. However, the development of mechanisms 
to facilitate the parasites migration through host tissue, to defend against host 
immunological attack, and to otherwise ensure the completion of their life cycle would 
obviously have presented other selection pressures. It is not unlikely that the 
diversification and specialisation of proteinases has played a major role in the evolution of 
these processes. It would, therefore, appear that proteinases are essential for the survival 
of parasites and would represent suitable candidate molecules to which novel vaccine 
and/or rational drug design could be targeted.
1.5 : Schistosome Proteinases 
1.5.1: Proteinases of eggs and miracidia
The schistosome egg releases soluble proteins through its shell, which include proteolytic 
enzymes. Various activities have been reported from eggs, however, the genes encoding 
these activities have yet to be characterised. Early reports of proteinase activity from S. 
mansoni eggs centred around three partially-purified thiol proteinases, all of which cleaved 
the cathepsin B-specific substrate Z-Arg-Arg-aminofluorocourmarin(AFC) (Asch and
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Dresden, 1979; Sung and Dresden, 1986). These activities were localised to glands in the 
miracidium and were suggested to be involved in the passage of eggs through the wall of 
the intestine or bladder or in the penetration of the smooth muscle, extracellular matrix of 
the snail intermediate host by the hatched miracidiae. A novel cysteine proteinase activity 
from miracidiae and sporocysts of S. mansoni has been reported by Yoshino et al. (1993). 
The partially purified activity specifically hydrolyses Z-Phe-Arg-NHMec, diagnostic of 
cathepsin-L like activity. This activity was also suggested to be involved in penetration 
and infection of the snail.
Day et al. (1995) demonstrated that soluble extracts of eggs of S. japonicum 
contained cathepsin L-like activity with physical characteristics that were very similar to 
those of adult worms. They suggested that this activity may contribute to the pathology 
associated with schistosome eggs either directly, through its proteolytic activity or 
indirectly through immunological responses directed against the proteinase(s).
Leucine aminopeptidase (LAP) activity, a metalloproteinase, has been reported in 
secretions of S. mansoni eggs and hatching fluid. Bogitsh (1983) and Xu and Dresden 
(1986) demonstrated the presence of LAP activity in the germ cell of S. mansoni eggs, in 
the epidermis of the miracidium within the egg and also in the vitelline membrane 
surrounding the miracidium. They suggested that LAP plays a role in the hatching of the 
schistosome egg, possibly through the degradation of the egg shell to allow the release of 
the miracidium.
Doenhoff and co-workers have recently reported the purification of a serine 
proteinase, termed Sm480, from soluble extracts of S. mansoni eggs. This protein was
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highly immunogenic and cross-reactive antigens were detected in miracidiae, cercariae and 
adult worms (Curtis et a l, 1996; Doenhoff, 1998).
While the genes encoding these proteinases have yet to be characterised, it is not 
unlikely that these may also be expressed in other life cycle stages, based on similarities of 
enzyme activities. Indeed, whereas complete cDNA sequences encoding cathepsin L 
(Smith et a l,  1994; Michel et a l,  1995) and cathepsin D (Becker et al., 1995) have been 
characterized from adult schistosomes, partial cDNA sequences have been isolated for 
both of these from egg stage cDNA libraries as part of the ongoing World Health 
Organisation-sponsored Schistosoma Genome Initiative (Johnston, 1997).
1.5.2 : Proteinases of cercariae
The first step in human infection by schistosomes is the penetration of intact skin by free- 
living cercariae. The cercarial acetabular glands, the contents of which are released via 
ducts to the exterior following stimulation with skin lipids, contain multiple proteinases 
(Stirewalt, 1974; Minard et a l, 1997).
Various serine proteinases have been characterised from cercariae, however, of all 
schistosome proteinases reported to date, the best characterised is the cercarial elastase. 
This 28/30 kDa proteinase was purified from cercarial secretions and was shown to 
represent 90% of the total caseinolytic/gelatinlytic activity in these secretions (Marikovsky 
et al., 1988b). Both skin penetration and glycocalyx (tail) shedding are believed to be 
facilitated by the activities of cercarial elastase (Marikovsky et al., 1990a, 1990b; 
McKerrow et a l,  1991). Furthermore, a surface localised, schistosomular serine
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proteinase with characteristics similar to cercarial elastase has been implicated in 
immunomodulatory roles including the cleavage of host complement components 
(Marikovsky et a l ,  1988a, 1988b, 1990a, 1990b) and of host IgG and IgE bound to 
immune effector cells viaFc receptors (Auriault et al., 1981; Verwaerde et a l , 1988).
Cercarial elastase has been considered a potential target for immunological 
intervention as blocking of its action may interfere with the infection by cercariae and the 
subsequent development of schistosomules (Pierrot et a l,  1996; Darani et a l,  1997; 
Doenhoff, 1998). Immunisation with the proteinase elicited specific antibody responses 
which partially protected against challenge infection with S. mansoni cercariae (Darani et 
a l,  1997; Doenhoff, 1998).
In contrast to serine-like proteinases, other classes of proteolytic enzymes of 
cercariae have not been studied comprehensively. However, cathepsin L-like and cathepsin 
B-like activity have been recently described in extracts of S. mansoni cercariae (Dalton et 
a l,  1997a). These activities were also localised to the post acetabular glands and 
expression of these proteinases continues after the cercariae transform into schistosomules 
within the definitive host, unlike the cercarial elastase or other serine proteinase described 
which are exclusively expressed by cercariae (Dalton et a l,  1997a).
1.5.3 : Proteinases of adults and schistosomules
Schistosome cDNA libraries have been principally constructed using mRNA from adult 
schistosomes and hence more is known about genes encoding proteinases in the adult 
stage than in any of the other stages of the life cycle. Of the proteinase genes from adults, 
a number encode proteinases that appear to play a role in the nutrition of the parasite and
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these enzymes are discussed in detail in a later section (see section 1.6). In addition to 
proteinases involved in nutrition, a number of other proteinases have been described which 
appear to play roles in modulating the host immune response to the parasite.
Calpains are calcium-activated, cysteine proteinases, that are implicated in the 
regulation of cytoskeletal proteins, receptor proteins and protein kinases as well as in 
housekeeping roles such as intracellular protein turnover and membrane biogenesis in 
mammalian tissues. Calpains have a discrete large subunit of approximately 80 kDa and a 
small subunit of 30 kDa (Croall and Demartino, 1991). The large 80 kDa subunit appears 
to bear the proteolytic activity of calpains while the 30 kDa subunit plays a regulatory role 
in activating the large subunit (Goll et al., 1992).
Calpain activities have been purified from soluble extracts of S. mansoni (Siddiqui 
et al., 1993) and cDNAs encoding the large subunit isolated (Karcz et al., 1991; Andersen 
et al., 1991). The schistosome calpain has been localised to the surface epithelial layer and 
underlying muscle fibres and it appears that it is involved in the biogenesis of the 
schistosome surface membrane (Siddiqui etal., 1993). Immunological studies 
demonstrated that calpain was the target antigen of a murine CD4+ T lymphocyte clone, 
named clone B, that transfers protective immunity against challenge infection with S. 
mansoni (Jankovic et al., 1996). Mouse recipients of clone B displayed significant 
protection against cercarial challenge and, moreover, could kill schistosomula in vitro. 
Calpain is therefore considered a useful target for development of a schistosome vaccine. 
However, the recombinant 80 kDa subunit induced modest levels of protection (29-39%) 
against challenge infection of .S', mansoni in mice (Hota-Mitchell et al., 1997).
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1.6 : Proteinases involved in host haemoglobin degradation
Maturing and adult schistosomes feed on host red blood cells (RBC) and it is estimated 
that male and female adult S. mansoni ingest 39,000 and 330,000 RBC per hour, 
respectively (Timms and Bueding, 1959). Female adults are the egg-producing partner and 
would therefore require more energy than the male. Host haemoglobin (Hb) derived from 
the ingested RBC is essential for growth, development and reproduction of schistosomes 
(Timms and Bueding, 1959; Zussman et al., 1970; Jaffe et al., 1971). Upon ingestion by 
the schistosome, RBC are lysed by the action of haemolysin(s) within the esophagus of the 
parasties (Bogitsh, 1978; Kasschau et al., 1986). Hb released from RBC flows into the 
cecum of the schistosome where it is degraded to dipeptides or free amino acids which are 
either taken up or diffuse into the gastrodermal cells lining the schistosome cecum 
(Bogitsh, 1989) (Fig 1.2).
Nearly 40 years ago Timms and Bueding (1959) identified a proteolytic activity 
with a pH optimum of 3 .9 and a substrate preference for Hb in extracts of adult S. 
mansoni. They concluded that ‘the action of one or several proteolytic enzymes present in 
the alimentary canal of the worms’ may be responsible for the degradation of Hb. Since 
then, an expanding number of proteinases, active at acidic and neutral pH, have been 
implicated in Hb digestion. However, the precise molecular identity of these enzymes and 
the proteolytic pathways involved in the degradation of Hb still remain unresolved. 
Nonetheless, it was believed that inhibition of these enzymes would result in profound 
anti-parasitic effects. Accordingly, elucidation of how schistosomes digest Hb may identify 
new targets or strategies for designing anti-schistosomal drugs or developing vaccines.
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Fig. 1.2 : Schematic representation of putative mechanism of catabolism of host 
haemoglobin (Hb) from ingested red blood cells (RBC) by schistosomes (Adapted 
from Brindley et ah, 1997).
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1.6.1: Cathepsin B
Cathepsin B (EC 3 .4.22.1) is a category of papain-like, cysteine proteinases, located in 
lysosomes in mammalian cells. The schistosome cathepsin B, known also as Sm31, was 
first reported by Ruppel and co-workers while investigating the diagnostic potential of 
schistosome antigens (Ruppel etal., 1985). A 31 kDa protein was identified on 
immunoblots to be highly immunogenic in infected humans and mice and this protein was 
subsequently localised to the schistosome gut. Subsequently, a cDNA encoding Sm31 was 
isolated and sequence alignments revealed that the Sm31 gene encoded a cathepsin B, 
cysteine proteinase (Klinkert etal., 1987, 1989). At that time, Sm31 gained prominence as 
an important enzyme in the degradation of host hemoglobin and was thus termed 
‘hemoglobinase’ (McKerrow and Doenhoff, 1988).
Gotz and Klinkert (1993) expressed active, recombinant Sm31 in insect cells using 
baculovirus. Klinkert etal. (1994) reported a three-dimensional model for & mansoni 
cathepsin B based on the co-ordinates of the crystal structure of human cathepsin B. While 
the enzymes are similar in structure, examination of the models complexed with specific 
inhibitors revealed likely differences in inhibition profiles. It was confirmed that Z-Trp- 
Met-CHN2 is a more potent inhibitor of schistosome than of human cathepsin B, whereas 
the reverse is true with CA-074 (N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-isoleucyl-L- 
proline), a derivative of the epoxide E-64.
Lipps et al. (1996) expressed recombinant procathepsin B from S. mansoni in 
Saccaromyces cerevisiae. The recombinant enzyme was produced as the inactive 
proenzyme which required exposure to porcine pepsin in order to be processed to the
19
mature, active zymogen. The recombinant protease had a pH optimum of 6.0 against Z- 
Arg-Arg-NHMec and was inactive below pH 4. The recombinant yeast-expressed Sm31 
does not show a marked preference for Hb as substrate although it cleaves Hb at a few 
sites. Based on NH2-terminus analysis of digestion products of Hb, Lipps et al. (1996) 
calculated a consensus cleavage sequence of 6X1*181 (one, hydroxl, small aliphatic 
residue; six, aliphatic; eight, hydrophobic; *, cleavage point) (P3 P2 P1*P1’ P2’ P3’).
As mentioned earlier, it had been widely suggested that Sm31 was responsible for 
the degradation of hemoglobin within the gut of S. mansoni. However, recent studies 
indicate that this enzyme may not function alone in this process. It now appears that a 
battery of proteases are involved, including Sm31, in addition to other cysteine proteases 
including cathepsin L (below), cathepsin C and possibly schistosome legumain, as well as a 
cathepsin D aspartic protease (Fig 1.2).
1.6.2 : Cathepsin L
Cathepsin L (like cathepsin B) is a cysteine proteinase of the papain superfamily.
However, the prosegment of cathepsin Ls exhibits the ERFNIN motif of Karrer et al. 
(1993), which, together with other biochemical and structural characteristics, distinguishes 
cathepsin L and other cathepsins from cathepsin B. The ERFNIN motif is a distinctive set 
of conserved amino acid residues separated by three amino acids within a long, conserved 
alpha helix, constituting the core of a globular portion of the propeptide (Groves et al., 
1996; Coulombe et al., 1996). The ERFNIN motif is present in all papain, cathepsin L-like 
and cathepsin H-like cysteine proteinases but absent from the cathepsin B-like enzymes. In 
mammals, cathepsin L (EC 3.4.22.15) represents a major component of the lysosomal
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protein degradative system (Kirschke and Barrett, 1987). Human cathepsinL is also of 
particular interest because of evidence of its action in tumour invasion and metastasis 
(Yagel etal., 1989).
Activity ascribable to cathepsin L has been characterized from adult and other 
stages of schistosomes. Dalton and colleagues analysed the cysteine proteinase activity in 
soluble extracts and ES products of S. mansoni and S. japonicum using class-specific, 
synthetic peptidyl substrates including several that could discriminate between classes of 
papain-like, cysteine endoproteinases, namely cathepsin L (Z-Phe-Arg-NHMec, 
Z-Phe-Val-Arg-NHMec), cathepsin B (Z-Arg-Arg-NHMec; Z-Arg-NHMec) and 
cathepsin H (Z-Arg-NHMec). They concluded that the dominant proteinase activity 
between pH 4 to pH 6 was cathepsin L-like (Smith et a l,  1994; Day et al., 1995; Dalton 
et a l ,  1996), in contrast to cathepsin B as reported by other workers (Chappell and 
Dresden, 1986; Lindquist et a l , 1986; Wasilewski et a l,  1996). This activity against 
cathepsin L substrates at acidic pH is many fold greater than that for cathepsin B 
substrates, although cathepsin B activity with a pH optimum of ~6 against 
Z-Arg-Arg-NHMec is apparent (Dalton et al., 1996).
The activity of schistosome cathepsin L in tissue extracts of adult S. mansoni 
against the substrate Z-Phe-Arg-NHMec can be totally blocked by nanomolar 
concentrations of the diazomethanes Z-Phe-Ala-CHN2 and Z-Phe-Phe-CHN2. Z-Phe-Ala- 
CHN2 (K, 50% = 50 nM at pH 5) is a more potent inhibitor than Z-Phe-Phe-CHN2 (K, 
50% = 0.4 jam), which contrasts with mammalian cathepsin L where Z-Phe-Phe-CHN2 is 
the more potent inhibitor (Smith et al., 1994; Day et a l,  1995). Cathepsin L activity with
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similar biochemical properties has been detected in extracts of schistosome eggs (Day et 
al., 1995).
cDNAs encoding two cysteine proteinases with similarity to vertebrate cathepsins 
Ls have been characterized from S. mansoni (Smith et al., 1994; Michel et al., 1995) and 
homologues of both genes reported from S. japonicum (Day et al., 1995). Using PCR 
with degenerate primers designed to anneal to regions of cysteine proteinase genes 
encoding the active site residues Cys25 and Asnl79, Smith et al. (1994) isolated the first 
cathepsin L from adult S. mansoni cDNA. The full length transcript encoded a 
preproenzyme of 319 amino acid residues, including the signal peptide of 8 residues, a 
prosegment of 96 residues, and the mature enzyme of 215 residues. The apparent 
molecular mass of the mature enzyme is 24.3 kDa, with pi of 4.95. This proteinase has 
been termed SmCLl (S. mansoni Cathepsin LI) (S m iths al., 1994; Day etal., 1995) 
since a second cathepsin L gene has been reported from adult S. mansoni (Michel et al., 
1995). A cDNA encoding the apparent homologue, SjCLl, from S. japonicum has also 
been reported. While the cDNA encoding SjCLl did not encode the full-length 
preproenzyme, its deduced amino acid sequence revealed the mature proteinase would 
include 215 amino acid residues, o f similar length to SmCLl, with a predicted molecular 
mass of 24.1 kDa and pi of 5.63. The deduced amino acid sequences of SjCLl and 
SmCLl are 92% identical, and their eight S2 sub site residues are identical, indicative of 
identical substrate preferences (Day et al., 1995).
The cDNA encoding the second cathepsin L-like proteinase has been 
reported from S. mansoni (Michel et al., 1995) and S. japonicum (Day et al., 1995). This 
proteinase was termed SmCL2 and SjCL2, in each species (Day et al., 1995). The cDNA
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encoding the S. mansoni proteinase was isolated by subtractive hybridisation undertaken 
to locate female specific transcripts in adult S. mansoni. The S. japonicum homologue was 
isolated by heterologous DNA screening of a S. japonicum cDNA library using the 
radiolabelled cDNA sequence from S. mansoni as the probe. The preprocathepsin SmCL2 
contains 330 amino acids, including a signal peptide of 18, a pro-peptide of 97, and a 
mature enzyme of 215 amino acid residues. Its apparent molecular mass is predicted to be
24.3 kDa, with a pi of 9.25. Active site labelling and immunoblotting of schistosome 
extracts demonstrated that native SmCL2 is —31 kDa rather than 24.3 kDa as predicted 
from its deduced amino acid sequence, indicating that it may be glycosylated (Michel et 
al., 1995; Wasilewski et a l 1996). The amino acid sequence deduced from the cDNA 
encoding SjCL2 is comprised of 332 amino acid residues, with the signal peptide being 
comprised of 16 residues, the prosegment of 99 residues, and the mature enzyme of 217 
residues. The apparent molecular mass of SjCL2 is predicted to be 24.5 kDa, with a pi of 
8.98. The deduced amino acid sequences of SjCL2 and SmCL2 are 78% identical, and 
share five of eight S2 subsite residues (Day et al., 1995).
SmCL2 is over-expressed in females compared to male schistosomes and, in 
particular, is expressed in the reproductive system of the female parasite, and in the 
gynecophoric canal of the male. Based on this localisation, Michel et al. (1995) 
postulated that its role may be associated with the activation of phenyloxidase, an enzyme 
involved with cross-linking of eggshell proteins. They postulated, further, that SmCL2 
may play a role in altering the viscosity of the seminal and uterine fluids.
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Fig 1.3 : Alignment of the deduced amino acid sequence of SmCLl and SmCL2 with 
that of human cathepsin L (humL). Boxes denote conserved residues, and gaps have 
been introduced to maximise alignment. The putative signal peptide cleavage site is 
indicated by the solid arrow. The open arrow indicates the cleavage site between the 
propeptide and the mature enzyme. The ERFNIN-like motif and the conserved block in 
the propeptide are underlined. Cathepsin LI potential N-glycosylation sites are indicated 
with solid triangles. (Adapted from Dalton et al., 1996).
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The low level of identity (43%; see Fig. 1.3) of the deduced amino acid sequences 
between SmCLl and SmCL2 indicates that they are distinct proteins rather than products 
o f alleles of the same gene (Dalton etal., 1996). Also, SmCLl and SmCL2 differ in five of 
the six residues that constitute the S2 sub site of the active site, which determines the 
specificity o f the proteinase for its substrate; SmCLl contains Leu-67, Pro-68, Gly-133, 
and Ala 162 and Val 208, whereas cathepsin L2 contains Thr-69, Met-70, Ala-135, Gly 
163 and Asn 209 (refer to Fig 5.1).
Moreover, SmCLl contains 3 potential N-linked glycosylation sites in it mature 
region. SmCL2, by contrast, has a single potential site at Asn-209, however, since this Asn 
residue is contained within the S2 subsite, it is unlikely that this site would be glycosylated. 
Together, these structural differences suggest that SmCLl and SmCL2 perform separate 
functions (Dalton etal., 1996).
1.6.3 : Cathepsin D
Cathepsin D is a member of the aspartic proteinase sub-class of endoproteinases. cDNAs 
encoding cathepsin D have been isolated from S. japonicum (Becker et al., 1995) and S. 
mansoni (Wong etal., 1997). The schistosome proteinases are 48-55% identical to 
cathepsin D from mammalian species. However, the schistosome cathepsin Ds contain a 
carboxyl extension of about 43 residues which is absent from the mammalian cathepsin D. 
Other differences include the absence of a P-hairpin loop 3, which is cleaved during 
maturation of vertebrate cathepsin Ds to yield heavy and light chain subunits, differences 
in residues involved in substrate binding and specificity and in phosphorylation (Becker et 
al., 1995; Wong etal., 1997).
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Cathepsin D has been localised to the gastrodermal cells of both S. mansoni and 
S. japonicum, with higher levels of expression observed in female compared to male 
worms (Bogitsh and Kirschner, 1986, 1987; Bogitsh et al., 1992; Bogitsh and Brindley, 
unpublished data). Cathepsin D-Iike activity has been observed in soluble extracts and ES 
products of S. japonicum and S. mansoni (Becker et al., 1995). This activity was optimal 
at pH 3.0 to 4.0 and could be blocked by pepstatin. Further, the extracts and ES products 
digested human haemoglobin at a similar pH optimum and this activity was also inhibited 
by pepstatin (Becker et al., 1995). Together, these results indicate that that schistosome 
cathepsin D plays a central role in haemoglobin catabolism. Cathepsin D represents a 
potential target for anti-schistosomal therapies in view of its function and also differences 
between schistosome D and the homologous human cathepsin D may be exploitable in the 
design of anti-proteinase drugs.
1.6.4 : Cathepsin C
Cathepsin C, otherwise known as dipeptidylpeptidase I (DPP I) (EC 3.4.14.1) is a member 
of the papain family of cysteine proteinases. However, unlike papain or cathepsin L, DPP I 
is an exopeptidase which hydrolyses the removal of dipeptides from the amino terminus of 
the substrate. Mammalian cathepsin C exhibits an array of biochemical properties distinct 
from other papain-like enzymes including a dependence on halide ions for enzymatic 
activity. Furthermore, cathepsin C enzymes possess prosegments comprised of approx.
200 amino acid residues, compared to 60 to 100 residues of other papain-like proteinases 
(McGuire et al., 1997).
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Bogitsh and Dresden (1983) detected a cathepsin C-like activity in extracts of S. 
mansoni and S. japonicum and these activities were localised to the gastrodermis and the 
gut luminal surface. More activity was present in female worms compared to males and 
they proposed that cathepsin C was involved in haemoglobin degradation. Butler et a l
(1995) and Hola-Jamriska et a l (1998) have reported the sequence of a cathepsin C from 
S. mansoni and S. japonicum respectively. Northern blot analysis showed that S. 
japonicum cathepsin C was expressed in greater quantities in female as compared to male 
worms (Hola Jamriska et a l,  1998). Exoproteinases such as cathepsin C probably play a 
downstream role of degradation of Hb, acting on cleavage fragments released after 
degradation by endoproteinases (Fig 1.2).
1.6.5 : Schistosome legumain (Asparaginyl endopeptidase)
Asparaginyl endopeptidases are members of a novel family of cysteine proteinases which 
are termed legumains (EC 3.4.22.34), since they were first characterised from seeds of 
leguminous plants. These enzymes cleave peptide bonds on the carboxyl side of Asn 
residues except where the Asn occurs at the NH2 terminus or at the second position from 
from the NH2 terminus or when the Asn is glycosylated. Legumains function in the post- 
translational modification of storage proteins in legume seeds by cleaving asparaginyl 
peptide bonds between pro-peptides and mature proteins (Ischii, 1994).
Like cathepsin B Sm31 proteinase, a second schistosome antigen, termed Sm32, 
was first identified as an immunogenic component of soluble extracts of schistosomes 
(Ruppel, 1985a, 1987). Davis et al. (1987) isolated the cDNA encoding Sm32, however, 
its identity was in question as it showed no obvious similarity to other proteinases in the
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databases. The sequence of Sj32, the S. jctponicum homolog of Sm32, has also been 
reported (Mercklebach etal., 1994). However, the identity of Sm32/Sj32 was clarified 
when sequences encoding asparaginyl endopeptidases from seeds of legumes were shown 
to be similar to Sm32 (Ischii, 1994; Dalton et a l,  1995a). Subsequently, Dalton et al. 
(1995b) demonstrated the presence of asparaginyl endopeptidase activity in soluble 
extracts of S. mansoni using diagnostic substrates developed by Kembhavi et al. (1993). 
The schistosome activity showed similar substrate specificity and inhibitor profile to the 
asparaginyl endopeptidase of the jack bean Canavalia ensiformis.
Monoclonal antibodies have been used to localise S. mansoni legumain to the 
epithelium of the gut in schistosomula and adults, to the ventral surface of adult males and 
to the cephalic glands of cercariae (Zhong et al., 1995). Historically, schistosome 
legumain has been considered to be centrally involved in the degradation of Hb, however, 
its function remains unclear. Its low specific activity against synthetic peptide substrates 
(Dalton et a l, 1995b) argues against a central role in Hb digestion, given the enormous 
numbers of RBC that schistosomes ingest (Lawrence, 1973). Further, Hb-degrading 
activity of the cysteine proteinases reputed to be involved in Hb digestion can be blocked 
by E-64 and diazomethanes (Wasilewski etal., 1996; Becker et al, 1995), neither of which 
are potent inhibitors of schistosome legumain (Dalton et a l,  1995b).
Dalton and Brindley (1996) suggested that, as with plant legumains (Ischii, 1994), 
schistosome legumain may process other proteins. Indeed, it may be involved in activation 
of the proteolytic enzymes, such as cathepsins L, D and C, which are directly involved in 
Hb degradation (Fig. 1.2). In support of this theory, the primary sequence of the 
cathepsins LI, L2, B, C and D contain asparagine residues in vicinity of the cleavage point
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of the pro- and mature forms of the enzymes (Dalton and Brindley, 1996). If this is the 
case, Dalton and Brindley (1996) suggested that drugs targeted at schistosme legumain 
may block the activation of other proteolytic enzymes directly involved in Hb digestion 
and thereby deliver a profound anti-schistosomal effect. Such a strategy would have to be 
selective, however, as a legumain has recently been reported from mammalian tissues 
(Chen etal., 1997).
1.7 : Aims of this project
The dominance of cathepsin L activity in extracts of schistosome tissues and in ES 
products (Dalton et a l,  1996) suggest that cathepsin Ls may be involved (with other 
proteinases) in Hb degradation. Recent studies on the related parasitic trematode Fasciola 
hepatica (liver fluke) have demonstrated that cathepsin Ls are involved in immune 
evasion, tissue penetration and nutrition mechanisms in these parasites (Smith et a l,  1993; 
Carmona et a l,  1993; Dowd et a l,  1994). Since SmCL2 has been localised to the 
reproductive organs and other sites distinct from the gut and gastrodermis of the 
schistosome (Michel et al, 1995), it is unlikely to be involved in Hb catabolism. One of the 
aims of this project was to determine if SmCLl possibly functions in the digestion of host 
Hb in S. mansoni.
A second aim of this project was to compare and contrast the biochemical 
characteristics of SmCLl and SmCL2 with regards to their substrate specificity. As 
described earlier, SmCLl and SmCL2 have many structural differences and the two 
enzymes are likely to perform separate functions (refer to section 1.6.2). Moreover, 
SmCLl shows only 44.3% identity to human cathepsin L, while SmCL2 is 52.3% identical
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(Dalton et al., 1996; see Fig. 1.3). These enzymes are considered potential targets at 
which to direct anti-schistosomal therapies. Indeed, the potential anti-schistosomal effects 
of drugs targeted at cysteine proteinases has been demonstrated by Wasilewski et al.
(1996) using morpholinourea-Phe-Ala-CHN2 and analogues. While these drugs would be 
inhibitors of both cathepsin L and B, they produced dramatic reductions in schistosome 
worm loads and fecundity in infected mice and were lethal to cultured schistosomula. 
Active site mapping using peptide substrates would provide leads into the design of 
specific peptide inhibitors of these enzymes.
Because parasite extracts contain many proteolytic activities, and additionally 
because of the paucity of material that can be obtained, it is virtually impossible to isolate 
individual proteinases directly from schistosome parasites. In order to study the 
biochemical characteristics of these enzymes, the immediate aim of this project was to 
express the proteinases in an active form in a recombinant expression system. The 
cathepsin L proteinases of Fasciola hepatica have been functionally expressed in the 
brewers yeast Saccharomyces cerevisiae (Dowd et al. 1997; Roche et al, 1997). The same 
system was employed for expression of the schistosome enzymes in the present study.
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Chapter 2
Functional expression of Schistosoma monsoni 
cathepsin LI (SmCLl) in Saccharomyces 
cerevisiae; purification of the recombinant enzyme, 
and localisation of the native enzyme in schistosome
tissues
2.1 : Materials
Bachem
Synthetic peptide substrates and inhibitors 
Bioraeda
‘Crystal/Mount’ medium 
Biorad
5-bromo-5-chloro-3-indoyl phosphate (BCEP), DC protein assay kit, goat anti-rabbit IgG 
conjugated to alkaline phosphatase, nitro-blue tétrazolium (NBT), prestained molecular 
weight markers.
Boehringer Mannheim
DIG glycan detection kit
Calbiochem
Goat anti-rabbit IgG-flourescein isothiocyanate (FITC) conjugate pre-adsorbed to bovine, 
horse, human and mouse sera
Difco Bacto
Yeast nitrogen base
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Gibco BRL, Life technologies Ltd
Synthetic oligonucleotides
Pharmacia LKB Biotechnology
Sephacryl S200 HR, DEAE Sepharose, nitrocellulose
Promega
Agarose, Deoxytrinucleotides, DNA molecular weight markers, restriction enzymes, DNA 
gel extraction kit, T4 DNA ligase, Taq DNA polymerase, Wizard DNA miniprep system.
Queensland Institute of Medical Research
DNA sequencing (Applied Biosystems)
Sakura Finitek 
Tissue-Tek O.C.T. medium
Sigma Chemical Company
2-mercaptoethanol, bovine serum albumin (BSA), bromophenol blue, Coomassie brilliant 
blue R, D-glucose, dithiothreitol (DTT), ethidium bromide, gelatin, peptone, sodium 
dodecyl sulphate (SDS), streptomycin, tetracycline, Tween 20, uracil, yeast extract.
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2.2 : Methods
2.2.1 : Cloning of Schistosoma mansoni cathepsin LI into yeast expression vector
The isolation of the complete preprocathepsin SmCLl from an adult S. mansoni cDNA 
library has been previously described (Smith et al., 1994). Primers designed to anneal to 
the 5’ and 3’ termini of the SmCLl cDNA, termed SmCLIF and SmCLlR were 
synthesised.
SmCLIF: CGC AAG CTT ATG CCT GTA AAC CTC GAG TAC 
SmCLlR. CGC AAG CTT CCC CTA GTA GAT CAT CGC TGA
The primers included Hind III recognition sequences (underlined). These primers were 
used to re-amplify SmCLl by PCR from the original template which had been cloned into 
pGEM-T as described by Smith et al. (1994) for insertion into the yeast expression vector 
pAAH5 (Ammerer, 1983). Cycling conditions in the PCR were as follows : 5 min at 94°C 
initial denaturing step, 25 cycles of denaturation at 94°C, primer annealing at 50°C for 1 
min and extension at 74°C for 1 min, and a final extension step of 5 min at 74°C. 
Amplified fragments were electrophoretically separated in a 1% agarose-Tris-acetate gel. 
The gel was stained with ethidium bromide and the a band of the expected size (approx. 1 
kb) corresponding to the SmCLl amplified product was excised from the gel and eluted 
from the agarose using a Gel Extraction Kit (Promega) according to the protocols
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provided by the manufacturer. The purified fragment was digested with Hind III and 
ligated to Hind III linearized pAAH5 as similarly described by Sambrook et al. (1989)
2.2.2 : Transformation of E. coli and preparation of plasmid DNA
Escherichia coli strain MC 1061 was used as the host for pAAH5 plasmid and 
recombinant construct propagation and manipulations. Fresh competent cells were 
prepared using the calcium chloride method and transformation was performed according 
to standard protocols (Sambrook et al. 1989). E. coli cells were normally cultured on 
Luria Bertani (LB) medium. One hundred p.g/ml ampicillin was added to plates and liquid 
media of cultures of cells harbouring plasmids. Positive or recombinant colonies were 
picked from the plates and replicated in fresh media. Plasmid DNA was prepared using the 
Wizard miniprep DNA purification system (Promega) according to the suppliers 
protocols. An internal Eco R1 site within the SmCLl cDNA was used to determine the 
correct orientation of the SmCLl insert within the vector by restriction mapping. DNA 
was visualised by electrophoresis on agarose-TAE gels. A clone with the correct 
orientation for expression was isolated and named pAAH5.SmCLl.
2.2.3 : DNA sequencing
The complete DNA sequence of selected recombinant clones was determined by an 
automated method (Applied Biosystems) at the DNA Sequencing Unit, The Queensland 
Institute of Medical Research, Brisbane, Australia.
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2.2.4 : Transformation and culturing of Saccharomyces cerevisiae
Saccharomyces cerevisiae strain DBY746 (Mat a  his3-Dl-leu2-3 leu2-112 ura3-52 
trp l-289a ) (Yeast Genetic Stock Centre, Department of Biophysics and Medical Physics, 
University of California, Berkeley, CA, USA) was transformed with the pAAH5.SmCLl 
construct or pAAH5 containing no insert by the lithium acetate method (Carter et al., 
1987). Yeast transformants were cultured on selective minimal media (Bacto Yeast 
Nitrogen Base 6.7 g/l„ D-glucose 20 g/1, uracil 20 mg/ml in 0 .1M phosphate buffer, pH
5.5, polymerised with 20 g/1 Difeo no. 1 agar) at 30°C for 3-4 days. DBY746 strain was 
routinely maintained in buffered complex media (YEPD): Yeast extract 10 g/1, peptone 20 
g/1, D-glucose 20 g/1 in 0.1M phosphate buffer pH 6.5.
2.2.5 : Expression and purification of yeast-expressed recombinant cathepsin LI 
(ySmCLl).
Recombinant yeast cells were grown in selective minimum media at 30°C in flasks with 
vigorous agitation and the O D 6oo was monitored. Initially, ten clones were cultured in 300 
mis of medium and analysed for expression of recombinant SmCLl (ySmCLl). Cultures 
were harvested when they reached the early stationary phase. The cells were collected by 
centrifugation, and the supernatant assayed for cathepsin L proteinase activity using the 
fluorogenic substrate Z-Phe-Arg-NHMec (see below). One clone producing the most 
enzyme was used for further analysis. For large-scale expression of yeast recombinant 
SmCLl (ySmCLl), yeast cells were grown in an automative fermentor (New Brunswick, 
model 101) in selective minimal media at 30°C until the O D 6oo reached 1.4. Yeast cells 
were removed by centrifugation and the supernatant stored at 4°C.
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Ten litres of pAAH5.SmCLl-transformed yeast supernatant was concentrated at 4°C to 
20 ml in an Amicon 2000A concentrator using an Amicon YM3 membrane (3000 Da 
molecular mass cut-off). The concentrate was applied to a Sephacryl S200HR (Pharmacia) 
gel filtration column (2.6 x 74.5 cm) equilibrated in 0.1M Tris-HCl, pH 7.0, at 4°C. 
Proteins were eluted from the matrix with the 0.1M Tris-HCl, pH 7.0, and fractions (5 ml) 
containing cathepsin L activity, measured using the fluorogenic substrate Z-Phe-Arg- 
NHMec (see below), were pooled. The pooled fractions were concentrated to 3 ml, 
dialysed against 20 mM Tris-HCl, pH 7.0, and applied to a QAE-Sephadex A50 column 
(10 cm x 2.5 cm) (Pharmacia), equilibrated in the same buffer. The column was washed 
with the equilibration buffer (375 ml) after which bound molecules were eluted in a 0 - 
500 mM NaCl gradient. Fractions (5 ml) containing cathepsin L activity were pooled, 
concentrated as above, and stored at -20° C.
2.2.6 : Fluorimetric enzyme assays
Routine assays to detect cathepsin L-like activity in supematents and purified fractions 
were carried out using the fluorogenic peptide Z-Phe-Arg-NHMec as substrate. The 
substrate was stored as a 1 mg/100 p.1 stock solution in dimethylformamide. Assays were 
carried out using a final concentration of 10 pM substrate in 0.1 M sodium phosphate 
buffer, pH 6.5, containing ImM dithiothreitol, in a volume of 1 ml. The solutions were 
incubated at 37°C for 1 h before the reaction was terminated by the addition of 0.2 ml of
1.7 M acetic acid. The amount of NHMec released was measured with a fluorimeter (370
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nm excitation and 440 nm emission). One unit of enzyme activity was defined as that 
amount which catalyzed the release of 1 (imole NHMec/min at 31°C.
2.2.7 : Adult worm extract (WE) and Excretory/Secretory (ES) products
Adult worms, freshly perfused from the mesenteric veins of mice, were sonicated in PBS 
using a Branson Sonicator set at repeating duty cycle 2.5 and output of 25%. Prior to five 
x 1 min sonication cycles, cellular debris was removed by centrifugation at 12,000 xg for 
30 min at 4°C. Supernatants were removed, aliquoted and stored at -20°C until required. 
For the preparation of ES products, freshly perfused worms were cultured overnight at 
37°C in RPMI-1640 medium supplemented with 20 (ig/ml streptomycin and 20 [ig/ml 
tetracycline. Medium was removed and concentrated twenty fold in Centricon 10 
cartridges (Amicon) according to the manufacturers instructions and the concentrated 
supernatant stored at -20°C.
2.2.8 : Protein concentration estimation
Measurements of protein concentration were accomplished using the DC Protein Assay kit 
from Bio-Rad according to the manufacturers instructions. Bovine serum albumin was 
used as a protein standard.
2.2.9 : SDS-Polyacrylamide gel electrophoresis (SDS-PAGE)
Protein samples were analysed by one dimensional 12% SDS-PAGE gels according to the 
method of Laemmli (1970). Samples were prepared in reducing sample buffer (0.12 M
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Tris-HCl, pH 6 8, 5% (w/v) SDS, 10% (w/v) glycerol, 0.01% (w/v) Bromophenol Blue 
and 5% 2-mercaptoethanol) and boiled for 5 min. Gels were stained for protein with 
Coomassie brilliant blue R.
2.2.10 : Immunoblotting
Adult schistosome worm extracts (WE), ES products, concentrated supernatant from 
yeast transformed with pAAH5.SmCLl and purified recombinant enzyme were separated 
by reducing SDS-PAGE and electrophoretically transferred to nitrocellulose paper using a 
semi-dry electroblotting system. Following blocking of non-specific binding in 1% bovine 
serum albumin in TBST (10 mM Tris, pH 8, containing 150 mM NaCl, 0.1% Tween), the 
nitrocellulose membrane was incubated in anti-SmCLl or non-immune rabbit serum at 1 in 
500 dilution in the same buffer. Alkaline phosphatase-conjugated anti-rabbit IgG was used 
to detect the bound immunoglobulin using nitro-blue tetrazolium (NBT) and 5-bromo-4- 
chloro-indolyl phosphate (BCIP) as substrates for the alkaline phosphatase.
2.2.11 : Zymography
Purified ySmCLl was analysed for proteinase activity in non-denaturing gels containing 
co-polymerized gelatin according to the method of Dalton and Heffernan (1989). Briefly, 
proteins were applied to 10% non-SDS polyacrylamide gels, with the seperating gel 
containing 0.1% gelatin. After electrophoresis, the gels were washed for 2 X 15 mins in 
0.1 M phosphate buffer, pH 6.5. The gels were then incubated in the same buffer 
overnight at 37°C. Gels were subsequently stained with coomassie and destained in 20% 
(V/V) methanol, 10% acetic acid.
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2.2.12 : Glycosylation studies
Glycoproteins were detected using the DIG Glycan Detection Kit (Boehringer Mannheim) 
according to the manufacturers instructions. Briefly, proteins were separated on 12% 
SDS-polyacrylamide gels and transferred to nitrocellulose as described above (see section 
2.2.10). Filters were then incubated in 10 mM sodium metaperiodate, in 0.1 M sodium 
acetate buffer pH 5.5 for 20 min at room tempeture. After washing in phosphate buffered 
saline (PBS) the filter was incubated in 1 |il of digoxigenin-O-3-succinyl-s-aminocaproic 
acid hydrazide dissolved in 5 ml sodium acetate buffer, pH 5.5 for 1 h at room tempeture. 
Digoxigenin (DIG), a spacer linked steroid hapten, covalently binds to aldehyde groups of 
sugars of glycoconjugates. DIG labeled glycoproteins are subsequently detected in an 
enzyme immunoassay using a DIG-specific antibody conjugated with alkaline phosphatase. 
Transferrin and creatinase were used as positive and negative controls, respectively.
2.2.13 : Hemoglobin proteolysis by ySmCLl
Hemoglobin was prepared as described previously (Becker et al, 1995). Hemoglobin (150 
(.ig) was incubated with ySmCLl (20 (ig) at 37°C for 18 h in the presence of 1 mM 
dithiotreitol. Digestions was carried out in the following buffers; 0.1M sodium acetate pH 
4.0 and 4.5; 0 .1M sodium citrate, pH 5.0 and 5.5 and 0.1M sodium phosphate, pH 6.0 and
6.5, with the ionic strength of each buffer equalized to 100 mM using NaCl. Following the 
incubation, the reaction products were analyzed by 15% SDS-PAGE under non-reducing 
conditions and staining with Coomassie Brilliant Blue R.
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2.2.14 : Preparation of rabbit anti-SmCLl serum
Recombinant SmCLl was expressed in Escherichia coli and purified by affinity 
chromatography as described in Chapter 4 (section 4.2.2). The bacterially-expressed, 
recombinant protein (termed bSmCLl) was used to immunise a rabbit and produce a 
highly specific anti-bSmCLl serum (section 4.2.4).
2.2.15 : Imraunolocalisation of SmCLl in adult worms.
Mixed-sex adult worms were perfused from mice and then embedded in Tissue-Tek 
O.C.T. medium (Sakura Finetek) after which 10 |iM sections were cut using a cryostat 
microtome. The sections were mounted on glass slides and air dried for 4 h. Sections were 
fixed in ice-cold acetone for 2 min, washed in PBS and incubated in goat normal serum 
diluted 1:5 in PBS for 30 min to inhibit non-specific background with the secondary 
antibody (below). After washing in PBS, sections were incubated in rabbit anti-bSmCLl 
or control serum diluted 1:200 inPBS/1% bovine serum albumin (BSA) for 1 hour. 
Sections were washed in PBS, and incubated in goat anti-rabbit conjugated to fluorescein 
isothiocyanate (Calbiochem) diluted 1:100 inPBS/1% BSA (The conjugated antibody had 
been pre-adsorbed to bovine, horse, human and mouse sera by the manufacturer). All 
incubations were performed at room temperature. After further washing in PBS, sections 
were mounted in “Crystal/Mount” medium (Biomeda), viewed under UV light on an 
Olympus BX60 microscope, and photographed.
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2.3 : Results
2.3.1 : Cloning of SmCLl in pAAH5 expression vector
In order to analyse the biochemical properties of S. mansoni cathepsin LI, the cDNA 
encoding the complete pre-pro-cathepsin L was subcloned into the Saccharomyces 
cerevisiae expression plasmid pAAH5. pAAH5 is a shuttle vector with the yeast 
replication region of the 2-micron circle and the E. coli replication region of pBR322. The 
yeast LEU2 gene for leucine synthesis provides a selective marker in S. cerevisiae and the 
ampicillin resistance gene is used for selection of transformants in E. coli. The Hind III 
cloning site is flanked at the 5’ side by the promotor and the untranslated leader of the 
yeast alcohol dehydrogenase gene ADC1 containing the ribosome-binding site (Ammerer, 
1983). The SmCLl insert provided the translation and termination codons itself The 
signals required for post-translational processing and intracellular sorting of the 
proenzyme are encoded by the prosegment-encoding sequences within the SmCLl gene 
(Fig 2.1).
The complete cDNA encoding pre-pro SmCLl was amplified using two primers (SmCLIF 
and SmCLlR) with Hind III recognition sequences incorporated. A band of the expected 
size (approx. 1 kb) was amplified and this fragment digested with Hind III and ligated into 
Hind III linearized pAAH5 plasmid. E. coli strain MC1061 cells were transformed with 
resulting constructs and transformed clones were selected on LB medium containing 
ampicillin. Ten clones harbouring plasmids were selected and analysed for the presence of 
ligated insertions. Plasmid DNA was purified from the clones, digested with Hind III and
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visualised on agarose gels. An example o f a clone containing the expected 1 kb insert is 
shown in Fig. 2.2, lane 2.
SmCL1 1000 bp
PRK PRO M ATURE
H im ! I E  Eco  R I  H ind  I I !
Fig 2.1 : Diagrammatic representation pAAH5.SmCLl construct
An internal Eco R l site within the SmCLl cDNA allowed us to determine the correct 
orientation of the SmCLl insert within the vector (Fig. 2.1). Plasmids containing the 
insert from a number of clones were digested with Eco Rl and examined for the presence 
of a 2.4 Kb band indicating that the SmCLl cDNA had ligated into the vector in the
correct orientation for expression (Fig. 2.2, lane 3). Constructs containing inserts that had 
ligated in the wrong orientation resulted in the presence of a 1.6 kb band instead of the 2.4 
kb fragment. A clone with the correct orientation for expression was selected for further 
experiments and this clone was termed pAAH5.SmCLl. Sequence analysis of the 
complete insert confirmed that no mutations had occured during PCR amplification.
Fig 2.2 : Cloning of SmCLl into the yeast expression vector, pAAH5
TAE agarose gel showing cloning and orientation of insert. Lane 1; 1 kb molecular weight 
ladder. Lane 2; digestion of pAAH5.SmCLl construct with Hind HI reveals the expected 
1 kb fragment; Lane 3; digestion with Eco R1 shows the 2.4 kb band demonstrating the 
insert had ligated into the vector in the correct orientation for expression.
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2.3.2 : Expression of SmCLl in yeast
Yeast strain DBY746 cells were transformed with the pAAH5.SmCLl construct or the 
pAAH5 plasmid containing no insertion as a negative control for expression. Recombinant 
yeast clones were selected on minimal medium and ten clones were chosen for initial 
studies. The selected clones were cultured in shake flasks until cells entered early 
stationary phase and supernatants were assayed for cathepsin L activity using the 
fluorogenic peptide substrate benzyloxycarbonyl-phenylalanine-arginine-7-amido-4- 
methylcoumarin (Z-Phe-Arg-NHMec). This substrate is efficiently cleaved by cathepsin Ls 
in the presence of a reducing agent, in this case dithiothreitol (DTT), releasing the 
fluorogenic leaving group methylcourmarin (Mec). This fluorescence can be used to 
quantify the level of cathepsin L activity (Barrett and Kirschke, 1981).
Supernatants harvested from cells transformed with the pAAH5.SmCLl construct showed 
significant activity against Z-Phe-Arg-NHMec (Fig 2.3). This activity was enhanced over 
five-fold by DTT and was completely inhibited by the cathepsin L-specific inhibitor 
benzyloxy carbonyl-phenylalanine-alanine-diazomethylketone (Z-Phe-Ala-CHN2), results 
characteristic of cathepsin L-like, cysteine proteinase activity. Supernatants of yeast 
transformed with pAAH5 plasmid exhibited no activity, while S. mansoni crude worm 
extract, which contains cathepsin L activity (Dalton et al., 1996) showed a similar profile 
to supernatants from cells transformed with pAAH5.SmCLl. A clone displaying the 
highest level of cathepsin L activity was chosen and used for further studies. Expression 
was scaled up by subsequently culturing this clone in an automative 10 L fermenter. The 
fermenter allowed optimisation of yeast growth by control of parameters such as
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temperature, aeration and agitation resulting in enhanced expression levels of the
recombinant SmCLl
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Legend : FA = Z-Phe-Ala-CHN2
ySmCLl = supernatant from yeast cells transformed with pAAH5.SmCLl 
pAAH5 -con = supernatant form yeast transformed with pAAH5 control plasmid 
WE +con = S. mansoni crude worm cxtract positive control
Fig 2.3 : Fluorimetric enzyme assay for the presence of cathepsin L activity in 
supernatants of yeast transformed with pAAH5.SmCLl
Supernatants of yeast cells transformed with pAAH5.SmCLl or plasmid pAAH5 were 
assayed using Z-Phe-Arg-NHMec as substrate in the presence or absence of the reducing 
agent DTT or the specific cathepsin inhibitor Z-Phe-Ala-CHN2 (Results are the means of 
experiments performed on ten clones).
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2.3.3: Purification of recombinant ySmCLl
Yeast-expressed recombinant SmCLl (ySmCLl) was purified from yeast culture media by 
gel filtration on Sephadex S200HR followed by ion exchange chromatography on QAE- 
Sephadex matrix. Fractions were assayed for cathepsin L activity using Z-Phe-Arg- 
NHMec as substrate as outlined above. Z-Phe-Arg-NHMec-cleaving activity resolved as 
two peaks on the S200 HR matrix (Fig 2.4A). Fractions corresponding to both peaks were 
separately pooled and concentrated by ultrafiltration using an Amicon 50A stir-cell 
concentrator fitted with a 3 kDa cut-off membrane. Although the total activity was greater 
in the first peak (peak I) compared to the second peak (peak II), further purification was 
performed with the enzyme pool of peak II since it contained proteinase with much higher 
specific activity (peak I, 0.169 U/mg, peak II, 0.55 U/mg) (Table 1). The activity in both 
peaks was completely inhibited by Z-Phe-Ala-CHN2 and enhanced by DTT (data not 
shown).
When the peak II activity was applied to the ion exchange QAE-Sephadex matrix, a large 
proportion of the proteolytic activity did not bind to the resin and was collected in the run- 
through fractions (Fig 2.4B). Subsequent elution of the column with a 0-500 mM NaCl 
gradient resulted in the release of proteolytic activity over a wide range of fractions (fig. 
2.4B). However, this pool exhibited a low specific activity of 0.098 U/mg. In contrast, the 
proteinase in the run-through from QAE Sephadex exhibited a specific activity of 2.5 
U/mg which represented a 42-fold enrichment compared to the fermentation supernatant 
(Table 1).
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SmCLl on gel filtration and ion exchange matrices.
TABLE 1 : Chromatographic purification of yeast-expressed recombinant
Protein
(mg)
Activity
(U)
Sp. activity 
(U/mg)
Yield
(%)
Purification
fold
Culture medium 53.1 3.24 0.06 100 1
S200HR 
Peak 1 12.52 2.12 0.169 65.4 2.82
S200HR 
Peak II
2.03 1.12 0.55 34.6 9.17
QAE-Sepadex
Pool
0.18 0.45 2.5 14.0 42.0
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Fig 2.4 : Purification of ySmCLl
Profiles of elution from a Sephacryl S200HR column (A) and QAE-Sephadex column (B). 
Protein elution was monitored by absorbance at 280nm (lines) and cathepsin L activity 
was assayed using the synthetic, fluorogenic substrate Z-Phe-Arg-CHN2 (dots). The salt 
gradient (0-500 mM NaCl) during QAE-Sephadex chromatography is represented by the 
dotted line and fractions pooled are indicated.
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2.3.4 : SDS-PAGE and immunoblotting
The run-through peak of the QAE-Sephadex column was divided onto three pools: 
the fractions from the ascending part of the peak (pool 1, fractions 2-10, Fig. 2.4B), those 
corresponding to the highest point of the peak (pool 2, fractions 11-15) and those from 
the descending portion (pool 3, fractions 16-20). These pools were concentrated on an 
Amicon 50A concentrator as before and analysed along with the concentrated yeast 
culture media and peak II from the S200HR column by SDS-PAGE (Fig 2.5, panel A). 
The gel demonstrated that a protein of 45 kDa was enriched close to purity (a minor band 
was seen at 40 kDa) using a purification scheme of gel filtration and anion exchange resins 
(Fig. 2.5A, lane 5).
Immunoblot analysis of replicate samples as those used in Fig. 2.5 A demonstrated that the 
45 kDa protein was reactive with antibodies prepared against bacterially expressed, 
recombinant SmCLl (anti-bSmCLl) (Fig. 2.5B) but did not react with pre-immunisation 
control serum (Fig. 2.5C). This data verified the identity of the 45 kDa protein as the 
recombinant SmCLl.
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Figure 2.5 : Chromatographic purification of ySmCLl on gel filtration and anion 
exchange matrices. Ten to 20 pg of protein of concentrated culture media (lane I), 
S200HR peak II (lane 2), and QAE-Sephadex run-through pool I (lane 3), pool II (lane 4) 
and pool III (lane 5) were separated by 12% SDS-PAGE under reducing conditions. Gels 
were either stained in Coomassie Brilliant Blue-R (Panel A) or transferred to nitrocellulose 
and probed with rabbit anti-bStnCLl serum (Panel B) or control serum (Panel C).
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2.3.5 : Glycosylation of ySmCLl
SDS-PAGE analysis showed that the molecular size of ySmCLl (45 kDa) was larger than 
the predicted size for the mature SmCLl (24.1 kDa) or the proenzyme (35 kDa). Since 
the SmCLl sequence revealed that this proteinase contains 3 potential N-linked 
glycosylation sites, the purified ySmCLl was examined for the presence of N-linked sugar 
residues using an enzyme immunoassay-based, glycan detection system. The recombinant 
protein showed a positive reaction for the presence of glucan, as did the positive 
glycosylated control transferrin (Fig 2.6). In contrast, the unglycosylated control 
creatinase did not react with the digoxigenin probe.
2.3.6 : Zymogram analysis of ySmCLl
Purified ySmCLl and soluble extracts of adult S. mansoni were analyzed for cysteine 
proteinase activity by gelatin-substrate PAGE. Two prominent gelatinolytic bands were 
observed in extracts of adult S. mansoni parasites, but were apparent only in the presence 
of the reducing agent cysteine (Fig. 2.7, Panel A,). These activities have been previously 
characterized in schistosome extracts to cathepsin L-like cysteine proteinase(s) (Dalton et 
al., 1996). Proteolytic activity was observed in lanes in which ySmCLl was applied and 
this activity resolved as a single band, which migrated more slowly than the two 
proteinases in the schistosome extracts. Like the activities in the schistosome extracts, 
activity of ySmCLl was enhanced markedly by the reducing agent, cysteine (Fig. 2.7, 
panel B). The optimum pH for the gelatinolytic activity of ySmCLl was determined to be 
pH 6.5 (data not shown).
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Fig 2.6 : Detection of glycoproteins using DIG-Glycan assay 
ySmCLl QAE Pool III (lane 1), positive control transferrin (lane 2) and negative control 
creatinase were separated by SDS-PAGE, transferred to nitrocellulose and assayed for the 
presence of glycan using the DIG-glycan detection kit. Molecular weight markers are 
indicated on left.
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Figure 2.7 : Gelatinolytic activity of ySmCLl.
Soluble extracts of adult S. mansoni (Panel A) and ySmCLl (Panel B) were analysed by 
10% gelatin-substrate PAGE (zymography) at pH 6.5 in the presence (lanes 1) and 
absence (lanes 2) of 10 mM cysteine.
2.3,7 : Haemoglobin Proteolysis by ySmCLl
As SmCLl has been implicated in the degradation of host haemoglobin, the ability of 
ySmCLl to digest human haemoglobin was examined. Haemoglobin was incubated with 
ySmCLl in buffers of varying pH in the presence of the reducing agent DTT and 
incubated overnight at 37°C. Reaction products were separated by SDS-PAGE and 
visualised by staining with Coomassie brilliant blue-R.
ySmCLl cleaved human haemoglobin, and based on the smeared appearance of the 
digested products, cleaved this substrate at more than one site (Fig 2.8). In contrast to 
peptide substrates (see section 4.3.4) and gelatin (section 2.3.6) where ySmCLl showed a 
pH optimum for activity of pH 6.5, it most efficiently cleaved haemoglobin at pH 4.5. 
Indeed, under the present assay conditions, haemoglobin was not digested at pH 5.0 or 
above.
2.3.8 : Immunolocalisation of native SmCLl in adult worms.
Thin frozen sections of adult male and female S. mansoni were probed with rabbit pre­
immunization and anti-b SmCLl sera in order to determine the site of expression of 
SmCLl in worm tissues. A series of 10 pm-thick longitudinal, diagonal and transverse 
sections were examined by light microscopy. No reactivity was observed on sections 
probed with pre-immunization serum (Fig. 2.9, Panel C). By contrast, immunofluorescent 
labeling was observed on sections probed with anti-bSmCLl serum at a) the tegument of 
adult worms of both sexes, with very prominent reactivity at and immediately below the 
tegument (Fig. 2.9, Panel A); and b) in the gastrodermal cells lining the lumen of the 
schistosome gut (Fig. 2.9, Panel B). No reactivity was evident at other sites or organs in 
the adult worms.
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Figure 2.8 : Hydrolysis of native human haemoglobin by ySmCLl. Native human 
haemoglobin was incubated with (+) and without (-) purified ySmCLl. Reactions were 
carried out at 3T C , at different pHs (indicated above) and in the presence of 1 mM DTT. 
After incubation for 18 h, the reaction products were resolved by 15% SDS-PAGE under 
non-reducing conditions and stained with Coomassie brilliant blue-R.
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Longitudinal sections of male (Panel A) and transverse sections o f female (Panel B) adult 
worms probed with rabbit anti-SmCLl serum followed by labeling with anti-rabbit- 
fluorescein conjugate. Control, pre-immunisation serum did not show any specific 
reactivity with schistosome tissues (Panel C). Intense reaction was observed in the 
tegument (Panel A) and in the gastrodermal cells lining the gut (Panel B); VT = ventral 
tegument; DT = dorsal tegument; P = parenchyma; LU = gut lumen; GA = gastrodermis, 
(see overleaf).
Figure 2.9 : Immunolocalisation of native SmCLl in adult schistosomes.
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Chapter 3
Functional expression of Schistosoma mansoni 
cathepsin L2 (SmCL2) in Saccharomyces
cerevisiae
3.1: Materials
Pharmacia
Quickprep mRNA Purification kit, Superóse 12 gel filtration column.
Promega
l,5-bromo-4-chloro-3-indoyl-ß-D-galactosidase (X-Gal), isopropylthio-ß-D-galactoside 
(IPTG), pGEM-T vector system.
Sigma Chemical Co.
Ampicillin, 1-3 -carboxy-2-3-¿r<mv-epoxypropionyl-leucylamido(4-guanido)-butane (E-64) 
Stratagene
ZAP-cDNA Synthesis kit
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3.2 : Methods
3.2.1 : cDNA preparation
mRNA was isolated from mature mixed-sex adult worms using a Quickprep mRNA 
Purification kit (Pharmacia) according to the manufacturers instructions. In brief, total 
RNA was isolated from adult worms and bound to oligo dT resin. Following elution of 
mRNA from the resin and ethanol precipitation of the mRNA, cDNA was synthesised 
using a ZAP-cDNA synthesis kit (Stratagene). cDNA was purified by phenol-chloroform 
extraction, precipitated in ethanol and stored at -20°C.
3.2.2 : Cloning of SmCL2 cDNA
The cDNA sequence encoding pre-pro SmCL2 has been published by Michel et al.
(1995). In this study, the full-length SmCL2 cDNA was isolated from total adult S. 
mansoni cDNA by PCR employing the primers SmCL2F and SmCL2R. These primers 
were designed based on the published SmCL2 sequence (GenBank accession no. Z32529) 
and contained Hind III restriction sites (underlined).
SmCL2F : 5’ CGCAAGCTTATGAAAGTTTTTCTTCTTCTTTTTTCAATTATTATTT 
CAGTTGCTATCGCCCAA 3’
SmCL2R : 5’ TTAAAGCTTCTAAAATGTAATGAATAG 3’
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Cycling conditions were as described in Chapter 2 (section 2.2.1). Reactions were 
analysed on 1% agarose gels and bands of the expected size of 1 kb were excised from 
the gel and purified as described in Chapter 2 (section 2.2.1). The purified DNA fragments 
were ligated to pGEM-T vector (Promega) according to the protocols provided by the 
manufacturer. Constructs were transformed into E. coli strain DH5a using the calcium 
chloride method (Sambrook el al., 1989). LB plates containing 100 mg/ml ampicillin, 0.5 
mM IPTG and 40 mg/ml X-Gal were used for blue/white selection of recombinant 
plasmids derived from pGEM-T. Clones were screened for the presence of inserts by PCR 
using ?iGTl 1 universal primers. Clones containing inserts of approximately 1 kb were 
sequenced as before to check for the presence of the SmCL2 cDNA.
3.2.3 : Subcloning SmCL2 cDNA into yeast expression vector
The SmCL2 cDN A sequence contains an internal Hind HI at nucleotide number 61 in its 
pro-region. As the yeast expression vector pAAH5 contains a unique Hind III cloning site, 
it was necessary to perform partial restriction digests on the cloned cDNA in pGEM-T in 
order to obtain the full length prepro-SmCL2 cDNA for insertion into pAAH5. This was 
performed by incubating the pGEM-T construct containing the amplified SmCL2 cDNA 
in sequential serial dilutions o f Hind III for 1 hour at 37°C. Digested fragments were 
separated on a 1.2% agarose gel and the fragment of approximately 1 kb, corresponding 
to the full-length prepro-SmCL2, was excised from the gel. This 1 kb DNA fragment was 
extracted from the agarose and the fragment cloned into pAAH5 as for SmCLl. Clones
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were examined by PCR in order to evaluate which clones contained inserts with the 
correct orientation for expression. The PCRs were performed utilising the primers used 
for initial cloning (SmCL2F and SmCL2R) and primers which were synthesised based on 
sequences within the promoter region (termed PROM) and terminator region (named 
TERM) of pAAH5.
PROM : GTT CCA GAG CTG ATG AGG
TERM : CCA GGT AGA CAA GCC GAC
A clone with the correct orientation for expression was isolated and named 
pAAH5.SmCL2. This recombinant plasmid DNA was then used to transform S. cerevisiae 
strain DBY746 cells as described in Chapter 2 (section 2.2.2).
3.2.4 : Purification of yeast-expressed recombinant cathepsin L2 (ySmCL2).
Recombinant yeast clones were monitored for production of ySmCL2 using the peptide 
substrate Z-Phe-Arg-NHMec as described for ySmCLl (Chapter 2, section 2.2.5). For 
purification of ySmCL2, 10 litres of culture supernatant was concentrated to 20 mis using 
an Amicon 2000A ultrafiltration stir-cell concentrator fitted with a YM3 (3 kDa cut-off) 
membrane. This concentrate was applied to a Sephacryl S300HR (Pharmacia) gel filtration 
column (2.6 x 60 cm), previously equilibrated in PBS at 4°C. Proteins were eluted from 
the matrix in PBS and fractions tested for cathepsin L activity using Z-Phe-Arg-NHMec as
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substrate. Fractions containing cathepsin L activity were pooled, concentrated to 500 pi, 
and applied to a Superose 12 gel filtration column (Pharmacia) equilibrated in PBS. 
Proteins were eluted from this matrix in PBS and fractions containing cathepsin L activity 
pooled and stored at -20°C.
3.2.5 : Preparation of rabbit anti-SmCL2 serum
Recombinant SmCL2 was expressed in Escherichia coli and purified by affinity 
chromatography as described in Chapter 4 (section 4.2.3). The bacterially-expressed, 
recombinant protein (termed bSmCL2) was used to immunise a rabbit and produce a 
highly specific anti-bSmCL2 serum (refer to Chapter 4, section 4.2.4).
3.2.6 : SDS-PAGE and immunoblotting
Proteins were analysed by 12% SDS-PAGE and immunoblotting using anti-bSmCL2 
serum as described in Chapter 2, sections 2.2.9 and 2.2.10 respectively.
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3.2 : Results
The cDNA encoding the pre-pro-SmCL2 had previously been isolated and cloned by 
Michel et al. (1995). Using the sequence published in GenBank (accession no. Z32529), 
primers were designed to anneal to the 5’ and 3’ ends of the cDNA, and these were used 
to amplify pre-pro-SmCL2 by PCR from adult S. mansoni total cDNA. A band of the 
expected size, 1 kb, was amplified (Fig. 3.1, panel A). This band was excised, purified and 
ligated into pGEM-T. Clones were selected by blue/white screening and the presence of 
inserts was confirmed by PCR using universal A.GT11 primers (Fig 3.1, panel B). Selected 
clones were subjected to DNA sequencing and the clones containing the full-length 
SmCL2 cDNA were identified. Sequencing also confirmed that no mutations had occurred 
during PCR amplification.
3.3.2 : Subcloning into pAAH5 yeast expression vector
The yeast expression vector pAAH5 contains a unique Hind III cloning site for insertion 
of cDNAs for expression (see Fig 2.1). As the SmCL2 cDNA contains an internal Hind III 
restriction site (Fig. 3.2A), it was necessary to perform partial restriction digests in order 
to clone the full-length fragment into pAAH5 plasmid DNA. When the pGem-T construct 
containing the cloned SmCL2 cDNA was incubated in Hind III, the fully digested 
fragment of 920 bp was observed (Fig. 3.2B, lanes 1-3). However, as the concentration of 
Hind n i  became limiting in the reaction, a minor band of approximately 1 kb, 
corresponding to the full-length cDNA, was detected and purified (Fig. 3.2B, lane 4). This
3.3.1: Isolation and cloning of SmCL2 cDNA
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fragment had Hind III overhangs on its 5’ and 3’ ends while the internal Hind IH site 
remained undigested, and this fragment was subsequently used for ligation into pAAH5.
Fig. 3.1 : Isolation and cloning of SmCL2 cDNA.
Panel A; Agarose gel analysis of PCR amplification of cDNA encoding SmCL2 from adult 
S. mansoni cDNA. Panel B; cloning of PCR product into pGEM-T. Twelve selected 
clones were analysed for the presence of inserts by PCR using universal AGT11 forward 
and reverse primers. A positive control insert (+, provided with the pGEM-T cloning kit) 
was included and DNA size markers are indicated.
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Fig. 3.2 : Partial restriction digests on SmCL2 cDNA in pGEM-T to isolate full- 
length fragment for insertion into pAAH5.
Panel A; Schematic diagram of SmCL2 cDNA fragment for insertion. Panel B; DNA was 
incubated in serial dilutions of Hind III (lane 1, 5 units enzyme; lane 2, 1 unit; lane 3, 0.2 
units, lane 4, 0.05 units) and separated on a 1.5% agarose gel. The full-length fragment is 
indicated by the arrow.
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The full length SmCL2 Hind Ill-digested fragment was ligated into Hind III- 
linearised pAAH5 and this construct was transformed into E. coli strain M CI061. 
Recombinant clones were selected on LB medium containing ampicillin and analysed for 
the presence of inserts by PCR employing primers based on sequences in the promotor 
(termed PROM) and terminator (TERM) regions of the pAAH5 vector. An example of a 
clone containing an insert of the expected size of 1 kb is shown in Fig. 3 .3B, lane 1.
Orientation of inserts within the vector was assessed by PCR employing the 
SmCL2R primer used for initial cloning from cDNA and the PROM and TERM primers.
A 1.3 kb fragment amplified in reactions containing a combination of the SmCL2R and 
PROM primers demonstrated the inserts which had ligated in the correct orientation for 
expression (an example is shown in Fig. 3.3, lane 2). No amplification occured in reactions 
employing the SmCL2R and TERM primers, confirming the correct orientation for 
expression in these clones (Fig. 3.3, lane 3). A clone, termed pAAH5.SmCL2, with the 
correct orientation for expression was selected for further experiments. The insert from 
this clone was sequenced and it was confirmed that the full-length SmCL2 cDNA had 
been cloned into the vector and this insert had indeed ligated in the correct orientation for 
expression.
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Fig. 3.3 : Cloning of SmCL2 into pAAH5 and assessing orientation of insert.
Panel A; Diagrammatic representation of construct. Panel B; PCR reactions to determine 
orientation of insert within pAAH5 of selected clone. Lane 1, reaction performed using 
PROM and TERM primers; lane 2, PROM and SmCL2R primers used; lane 3, TERM and 
SmCL2R primers used.
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Yeast strain DBY746 cells were transformed with the pAAH5.SmCL2 construct or the 
pAAH5 vector containing no insert and recombinant clones selected on minimal medium. 
Five clones transformed with the pAAH5.SmCL2 construct and five transformed with 
pAAH5 were selected and grown in 300 mis of minimal medium in shake flasks. Cultures 
were grown until cells entered early stationary phase and supernatants were assayed for 
cathepsin L activity using Z-Phe-Arg-NHMec as substrate.
Supernatants harvested from cells transformed with the pAAH5.SmCL2 construct 
showed significant activity against Z-Phe-Arg-NHMec (Fig 3.4). This activity was 
enhanced two-fold by DTT (ImM) and was completely inhibited by the cathepsin L- 
specific inhibitor Z-Phe-Ala-CHN2 (2 ^M), and by the general cysteine protease inhibitor 
l-3-carboxy-2-3-/ram-epoxypropionyl-leucylamido(4-guanido)-butane (E-64) (10 |jM). 
These results are characteristic of the presence of cathepsin L-like, cysteine protease 
activity. Yeast transformed with pAAH5 control plasmid exhibited no activity, while S. 
mansoni crude worm extract, which contains cathepsin L activity (Dalton et al., 1996) 
showed a similar profile to supernatants from cells transformed with pAAH5.SmCL2.
A clone displaying the highest level of cathepsin L activity was chosen and used 
for further studies. Expression was scaled up by subsequently culturing this clone in an 
automative 10 L fermentor as described in Chapter 2 (section 2.2.5). Ten litres of culture 
media was concentrated to 20 mis by ultrafiltration and then stored at -20°C until further 
required.
3.3.4 : Expression of SmCL2 in yeast
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Fig 3.4 : Expression of functionally active, recombinant SmCL2 in yeast 
Supernatants of yeast cells transformed with pAAH5.SmCL2 (ySmCL2) or control 
plasmid pAAH5 (pAAH5 -con) were assayed using Z-Phe-Arg-NHMec as substrate in the 
presence or absence of the reducing agent, DTT (ImM) and the specific cathepsin L 
inhibitor Z-Phe-Ala-CHN2  (F-A) (2 pM) or general cysteine protease inhibitor E-64 (10 
(iiM) (Results are the means of experiments performed on five clones). S. mansoni crude 
worm extract (WE +con), which contains cathepsin L activity, was used as a positive 
control in the assay.
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3.3.5 : Purification of yeast-expressed recombinant SmCL2
Yeast-expressed recombinant SmCL2 (ySmCL2) was purified from yeast culture medium 
using two gel-filtration columns with different separation ranges. The enzyme was first 
resolved on a Sephacryl S300HR column (effective separation range 10-1500 kDa). Z- 
Phe-Arg-NHMec-cleaving activity separated as 2 peaks (Fig. 3.5A). Peak n  had a higher 
specific activity than peak I (Table 3 .1) and this was subsequently used for further 
experiments.
Peak II was applied to the Superose 12 column (effective separation range 1-300 
kDa) and the cathepsin L activity separated as a single peak which eluted from the column 
after the main protein peak (Fig. 3.4B). The activity eluted from the Superose 12 was 
enhanced by DTT and inhibited by Z-Phe-Ala-CHN2 (data not shown).
3.3.6 : SDS-PAGE and immunoblotting
Pooled fractions from the S3 00 FIR and the Superose 12 gel filtration columns were 
analysed by 12% SDS-PAGE and immunoblotting using anti-bSmCL2. Gels stained with 
Coomassie Blue-R revealed a protein, of approx. 32 kDa in size, had been purified close 
to homogeneity (Fig 3.6 A). A protein of approximately 18-20 kDa was also evident.
The 32 kDa protein reacted strongly on immunoblots with anti-bSmCL2 serum, 
and the protein was seen to be present in concentrated supernatant and the S300 HR pool 
(Fig. 3.6B). The 18-20 kDa protein did not react with the anti-bSmCL2. A 32 kDa protein 
was also reactive with anti-bSmCL2 in S. mcmsoni crude worm extract. No bands were 
detected on replicate filters probed with pre-immune control serum (not shown).
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Fig 3.5 : Purification Profiles of ySmCL2, Profiles of elution from a Sephacryl S300HR 
column (Panel A) and Superose 12 column (Panel B) monitored by absorbance at 280nm 
(lines) and activity against Z-Phe-Arg-NHMec (dots). Pooled fractions are indicated.
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Fig 3.6 : Purification of ySmCL2 on gel filtration matrices
S. mansoni crude worm extract (WE), crude concentrated supernatant (SNC) from yeast 
culture expressing ySmCL2, S300 HR pool II (S300) and Superose 12 pool I (Supl2) 
were separated by SDS-PAGE and stained with Coomassie Blue-R (Panel A) or 
transferred to nitrocellulose and probed with anti-bSmCL2 serum (Panel B). Molecular 
weight standards (MW) are illustrated in kDa.
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Table 3.1: Purification of ySmCL2
Protein
(mg)
Activity
(U)
Sp. activity 
(li/mg)
Yield
(%)
Purification
fold
Culture medium 270.3 1.35 0.005 100 1
S300 Pool I 10.2 0.51 0.05 37.78 10
S300 Pool II 2.7 0.79 0.29 58.52 58.0
Superose 12 0.06 0.075 0.8 5.56 160.0
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Chapter 4
Comparative biochemical analysis of recombinant 
ySmCLl and ySmCL2 and investigation into 
expression of the native enzymes in schistosomes
4.1 : Materials
Advanced Biotechnologies
Total RNA Isolation Reagent
Qiagen
Ni-NTA Superflow nickel chelate resin, pQE.30 E. coli expression vector, QIAquick-spin 
columns, RGS-4H monoclonal antibody.
Sigma Chemical Company
Guanidine hydrochloride, imidazole, kanamycin, urea.
Superfos Biosector
Quil A/Saponin adjuvant.
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4.2 : Methods
4.2.1 : Cloning into E. coli expression vector
The cDNAs encoding the mature portion of SmCLl and SmCL2 were cloned into the 
bacterial expression vector pQE.30 (Qiagen) as recommended by the manufacturers. The 
pQE.30 vector contains an affinity tag consisting of six histidine residues (6xHis tag) 
which is placed at the carboxy-terminus of the recombinant protein. Recombinant proteins 
can therefore be purified in one step on nickel chelate (Ni-NTA) resin, utilising the 
histidines affinity for nickel ions (Janknecht el al., 1991). Also, a motif consisting of Arg, 
Gly, and Ser (RGS) is added to the N-terminus of the 6xHis tag. A monoclonal antibody 
raised to the RGS-4His epitope (Qiagen) can be used to screen for the presence of the 
recombinant protein on immunoblots. Recombinant constructs (termed SmCLl.pQE.30 
and SmCL2.pQE.30) were transformed into E. coli strain M l 5 and transformed clones 
selected on LB plates containing 100 p.g/ml ampicillin and 25 pg/ml kanamycin.
4.2.2 : Expression of recombinant proteins in E. coli
LB medium containing 100 pg/ml ampicillin and 25 pg/ml kanamycin was innoculated 
with cells transformed with SmCLl.pQE.30 or SmCL2.pQE.30 and incubated at 37°C 
with shaking until the optical density (OD6 0 0) reached 0.8. Expression of recombinant 
proteins was induced by addition of IPTG to a final concentration of 1 mM, and the cells 
were harvested 5 h later by centrifugation (this time point was found to give optimal 
expression levels o f recombinant proteins). The solubility and cellular location of
77
recombinant bSmCLl and bSmCL2 were determined according to the manufacturers 
instructions. Cell pellets were stored at -20°C until further required.
4.2.3 : Purification of recombinant proteins
The pellets of SmCLl.pQE.30- or SmCL2.pQE.30-transformed cells were resuspended in 
0.1 M sodium phosphate-0.01 M Tris-HCl (pH 8.0) containing 6 M guanidine 
hydrochloride at 5 ml per gram of cell pellet and sonicated for 8 min (duty cycle 25%, 
output 2.5) (Branson Sonifier 250, Branson Ultrasonics). The extracts were then 
centrifuged at 14,000 g for 30 min and the supernatants decanted. The supernatants were 
then incubated with 2 ml o f Ni-NTA Superflow resin (Qiagen) for 1 h at room 
temperature. The resin was packed into a column and washed with 5 volumes of 0.1 M 
sodium phosphate-0.01 M Tris-HCl (pH 7.2) containing 8M urea. Recombinant proteins 
were eluted with a linear gradient of imidazole (0-250 mM imidazole prepared in washing 
buffer) at 0.5 ml/min. One ml fractions were collected and analysed by 12% SDS-PAGE. 
Immunoblot analysis was also performed using the RGS-4his monoclonal antibody 
(Qiagen) engineered onto the C-tenninus of the recombinant protein expressed inpQE30.
4.2.4 : Anti-serum production
Purified proteins (termed bSmCLl and bSmCL2) were dialysed overnight in PBS at room 
temperature and used as antigens to raise an anti-bSmCLl and anti-bSmCL2 sera in New 
Zealand White rabbits. The rabbits were immunised five times with 20 (ig of bSmCL 1 or 
bSmCL2 suspended in QuilA adjuvant (Superfos Biosector) with intervals of 3 weeks
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between boosts. Bleeds were taken from rabbits at regular intervals (every 2-3 weeks) and 
used on immunoblots to check for the production of antibodies against the recombinant 
proteins.
4.2.5 : Characterisation ofySmCLl and ySmCL2 proteinase activity.
Substrate specificity and kinetics studies were carried out on purified ySmCLl and 
ySmCL2 using a bank of fluorogenic peptide substrates. The kinetic constants, £cat and Km 
were obtained by non-linear regression analysis using the Enzfitter program 
(Leatherbarrow, 1987). Active site titration using the cysteine proteinase inhibitor 1-3- 
carboxy-2-3-/ram-epoxypropionyl-leucylamido(4-guanido)-butaae (E-64) and the 
fluorogenic substrate Z-Phe-Arg-NHMec was performed to determine the molar 
concentration of active ySmCLl and ySmCL2 (Barrett et al., 1982).
For determination of the optimum pH of proteinase activity, the following buffers were 
used at a concentration of 50 mM; glycine, pH 2.5 to 3.0 and 9.1 to 10.0, sodium acetate, 
pH 3.5 to 5.5, sodium phosphate, pH 5.5 to 7.5 and Tris-HCl, pH 7.5 to 9.0. The ionic 
strength of each buffer was equalised to 100 mM using NaCl. Assays were conducted 
using Z-Phe-Arg-NHMec as substrate as described earlier (Chapter 2, section 2.2.6).
4.2.6 : Reverse transcription (RT)-PCR analysis
Eggs and miracidiae were isolated according to the method of Dalton et al. (1997b) and 
cercariae isolated as outlined by Dalton et al. (1997a). Total RN A was prepared from 
adult worms, cercariae, eggs and miracidiae using Total RNA Isolation Reagent
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(Advanced Biotechnologies) as per maufacturers instructions. RNA was purified by 
phenol/chloroform extraction followed by isopropanol precipitation and ethanol washes as 
described by the manufacturers. First strand cDNA was synthesised from 1 jLxg of total 
RNA using gene specific primers (termed L1RTR for SmCLl, L2RTR for SmCL2, and 
TPIR for triosephosphate isomerase (TPI) expression control, see below) with Superscript 
II reverse transcriptase (Gibco BRL) using the conditions recommended by the 
manufacturer. RNA was removed by hydrolysis before PCR by adding NaOH was to a 
final concentration of 0.4 M to each reaction and incubating the mix at 65 °C for 30 min. 
Acetic acid was then added to a final concentration of 0.4 M to neutralise the reaction 
mix. cDNA was purified on QIAquick-spin columns (Qiagen) and PCR reactions were 
carried out using 2 (j.1 of purified first strand cDNA. Thirty cycles were performed, each 
composed of a denaturation step for 1 min at 94°C, primer annealing for 1 min at 50°C 
and extension for 1 min at 72°C. Reaction products were separated on a 1.2% agarose
Primers used in RT-PCR reactions were as follows :
For SmCLl : LI RTF : CAA GGA ATG TGT GGC TCT TGT
L1RTR : GGA TGA CTA ATT CCA TGT TG
For SmCL2 : L2RTF : ATA TGG GAA TGA TGG ATG TCA
L2RTR : CTA AAA TGT AAT GAA TAG
For TPI : TPIF : GTT GGG GGG AAC TGG AAA ATG AA
TPIR : CAA AGG GTG CAT TCA CCG GAG AA
4.2.7 : Immunoblot analysis of soluble extracts and ES products
Soluble extracts o f female and male adult worms and cercariae were prepared as described 
in Chapter 2 (section 2.2.7). 10 fxg of total protein from each extract was separated on 
12% SDS-PAGE gels and transferred to nitrocellulose. Filters were probed with either 
anti-bSmCLl or anti-bSmCL2 and developed using anti-rabbit IgG-alkaline phosphatase 
conjugate as similarly described in chapter 2 (section 2.2.10).
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4.3 : Results
The mature forms of SmCLl and SmCL2 were expressed in E. coli, utilising the 
expression vector pQE.30. This vector contains a galactose-inducable promotor which 
allows high cell densities to be reached before expression of recombinant proteins is 
induced. After induction of expression, samples of cultures were taken at regular time 
intervals and cells analysed for the presence of an induced protein. In the case of SmCL2, 
a protein of approximately 32 kDa in size was seen to be expressed in cells one hour after 
induction with IPTG (Fig. 4.1). The intensity of this band was also seen to increase over 
time.
The protein solubility and cellular location of the bSmCLl and bSmCL2 was 
determined and neither protein was found in the soluble portion of the cytoplasm or to be 
secreted into the periplasmic space of the bacterial cell (data not shown). Rather, the 
recombinant proteins were expressed in insoluble inclusion bodies in the cytoplasm. 
Proteins were therefore solubilised in guanidine.HC1 and purified under denaturing 
conditions.
4.3.1: Expression and purification of recombinant cathepsin Ls from E. coli
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Fig. 4.1 : Induction of expression of recombinant bSmCL2 in E. coli cells
E. coli cells harbouring the expression plasmid were induced to express bSmCL2 by 
adding LPTG and samples were taken at 0, 1, 2, 3, 4 and 5 hours after induction. Cell 
pellets were boiled in 100 |jl of SDS-PAGE reducing sample buffer, separated on 12% 
gels and stained with Coomassie brilliant blue-R. The arrow indicates the protein of 
interest and pre-stained molecular weight markers (MW) are indicated in kDa
Affinity chromatography on nickel chelate resin was employed as the recombinant 
proteins contained a hexa-his tag at their C-terminus. A linear gradient of imidazol was 
used to elute bound proteins from the resin and fractions containing protein (monitored by 
OD28o) were analysed by SDS-PAGE. For bSmCL2, a protein of approx. 32 kDa was seen 
to elute from the resin and this protein was >95% pure (Fig. 4.2A). This protein eluted 
between 75 and 100 mM imidazole. A similar profile was observed for elution of 
recombinant SmCLl, except its molecular size was approximately 24 kDa (data not 
shown).
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Both the 24 kDa bSmCLl and 32 kDa bSmCL2 were analysed on immunoblots 
and the proteins reacted strongly with the monoclonal antibody to the polyhistidine ligand 
(Fig. 4.2B), verifying that the affinity purified molecules were indeed the recombinant 
proteins.
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Fig. 4.2 : Purification of recombinant cathepsin Ls from E. coli cells by affinity 
chromatography
Panel A; Profile of elution of bacterially-expressed SmCL2 fromNi-NTA resin. Fractions 
eluted from the resin (fraction numbers indicated) were analysed by SDS-PAGE to 
determine the presence and purity of recombinant protein. Panel B; Immunoblot analysis 
of purified, bacterially-expressed SmCLl (Panel 1) and SmCL2 (Panel 2) using the 
monoclonal antibody to the polyhistidine ligand.
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4.3.2 : Anti-serum preparation
Recombinant, bacterially-expressed SmCLl (bSmCLl) and SmCL2 (bSmCL2) were used 
as the antigens to prepare mono-specific rabbit anti-sera. Rabbits were given boosts at 2-3 
week intervals and the production of antibodies against the recombinant antigens analysed 
by immunoblotting. Both in the case of bSmCLl and bSmCL2, the production of 
antibodies was not detected until after the third boost. However, strong signals were 
detected, both against native and recombinant antigens, about 10-14 days after the fourth 
boost (Fig 4.3).
The anti-bSmCLl serum was seen to react strongly with the 24 kDa bSmCLl 
protein (Fig. 4.3A, lane 3). It also reacted with a protein of approximately 33 kDa in S. 
mansoni adult worm extract (Fig. 4.3A, lane 1) and purified, 45 kDa yeast expressed 
SmCLl (ySmCLl) (Fig. 4.3A, lane 2).
The anti-bSmCL2 serum reacted with a the 32 kDa bSmCL2 (Fig. 4.3B, lane 3). It 
also reacted with a protein in crude extracts of adult worms (Fig. 4.3B, lane 1) and 
purified ySmCL2 (Fig. 4.3B, lane 2), and both these proteins also had an apparent 
molecular weight of 32 kDa.
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Fig 4.3 : Production of anti-serum against recombinant SmCLl and SmCL2 
antigens.
Anti-serum raised against bSmCLl or bSmCL2 was used to probe recombinant and S. 
mansoni expressed native antigens of SmCLl (Panel A) or SmCL2 (Panel B). Lane 1; 
crude S. mansoni adult worm extract. Lane 2; purified ySmCLl (Panel A) or ySmCL2 
(Panel B) and lane 3; purified bSmCLl (Panel A) or bSmCL2 (Panel B). Molecular weight 
standards are indicated in kDa.
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4.3.3 : Substrate specificity ofySmCLl and ySmCL2.
The substrate specificity o f ySmCLl and ySmCL2 was characterised using a panel of 14 
fluorogenic peptide substrates. Kinetic constants were obtained for peptide substrates that 
are classically used for the characterisation of cathepsin proteinases, namely, Z-Phe-Arg- 
NHMec and Z-Arg-Arg-NHMec (Table 4.1 and Barrett and Kirschke, 1981). Both 
SmCLl and SmCL2 had a high affinity (A:cat/Am) for Z-Phe-Arg-NHMec, SmCL2 having 
approximately ten times higher affinity for this substrate than SmCLl. Both enzymes have 
a low affinity for Z-Arg-Arg-NHMec, with SmCL2 exhibiting negligible cleavage. The 
preference for a hydrophobic residue in the P2 position is consistent with the classification 
of SmCLl and SmCL2 as cathepsin Ls (Barrett and Kirschke, 1981).
Both enzymes also have a high affinity for Boc-Val-Leu-Lys-NHMec, with 
SmCLl having three-times higher affinity for this substrate over Z-Phe-Arg-NHMec in 
contrast to SmCL2 which has 3 times less affinity for Boc-Val-Leu-Lys-NHMec over Z- 
Phe-Arg-NHMec. It was found that SmCL2 does not cleave any other of the substrates 
examined while SmCLl has a broader range of specificity. In particular, SmCLl has a high 
affinity for H-Leu-Val-Tyr-NHMec (kcJ K m= 51.89 mM'1 s'1) and Suc-Leu-Tyr-NHMec 
(kcat/Km= 44.12 mM'1 s'1). Also, SmCLl exhibited low affinity for Tos-Gly-Pro-Arg- 
NHMec and Boc-Phe-Val-Arg-NHMec.
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Table 4 .1 : A comparison of the kinetic constants of ySmCLl and ySmCL2 on synthetic 
fluorogenic peptide substrates. ‘*’ indicates substrate cleavage of insufficient magnitude to 
allow calculation of enzyme kinetic results.
C a th cp sin  LI C ath ep sin  L2
Substrate
K m
(HM)
¿cat
(s*1)
¿cat/K m
(m M '1 s 1)
Km
( mM )
¿cat
(s'1)
¿cat/
(mM*1 s"1)
Z-Phe-Arg-NJ IMEC 11.81 0.424 35.90 3.2 1.31 406.3
Boc-Val-Leu-Lys-NHMEC 2.73 0.319 116.8 5.6 0.82 147.5
H-Leu-Val-Tyr-NHMEC 2.1 0.107 51.89 * * *
Suc-Leu-Tyr-NI IMEC 4.9 0.214 44.12 * * *
T os-Gly-Pro-Arg-NHMEC 6.8 0.016 2.38 * * *
Boc-Phe-Val-Arg-NHMEC 9.8 0.02 1.32 * * *
Z-Arg-Arg-NHMEC 3.27 0.004 1.10 * * *
Z-Phe-Ser-Arg-NHMEC 7.84 5.0xl0‘5 0.0064 * * *
Tos-Gly-Lys-Arg-NI IMEC * * * * * *
Tos-Gly-Pro-Lys-NHMEC * * * * * *
Tos-Leu-GIy-Arg-NHMEC * * * * * *
Tos-Val-Pro-Arg-NHMEC * * * * * *
Suc-Leu-Leu-Val-Tyr-NHMEC * * * * * *
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4.3.4 : pH activity profile ofySmCLl and ySmCL2
ySmCLl exhibited a broad bell-shaped activity profile against Z-Phe-Arg-NHMec (Fig. 
4.4). Its pH optimum for activity is approximately 6.5, but the enzyme retained over 50% 
of its activity as low as pH 4.5 and as high as pH 8.0. By contrast, ySmCL2 showed a 
much narrower range of activity against Z-Phe-Arg-NHMec. Its pH optimum is 5.5, but 
the enzyme was virtually inactive above pH 7.0. However, it did show a greater tolerance 
for acidic conditions compared to ySmCLl, retaining 50% of its activity at pH 3.2.
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Fig. 4.4 : pH profile of activity for recombinant ySmCLl and ySmCL2.
The activity o f the recombinant proteases against Z-Phe-Arg-NHMec was measured at 
different pHs. Results are the means of triplicate experiments and are plotted as relative 
activity.
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4.3.5 : RT-PCR analysis of life-cycle stages
RT-PCR analysis of cDNA isolated from various life-cycle stages of S. mansoni was 
performed to investigate the expression of SmCLl and SmCL2. These studies revealed 
that both enzymes were expressed by both males and females of the adult stage (Fig. 4.5). 
SmCLl was expressed by cerceriae (Fig. 4.5, Panel A, lane 6) but not by miracidiae or 
eggs (Fig. 4.5, Panel A, lane 4 and 5) while SmCL2 was not expressed by any of the larval 
stages (Fig. 4.5, Panel B, lanes 4-6).
TPI, a constitutively-expressed housekeeping enzyme (Hooker and Brindley,
1996), is expressed by all stages (Fig.4.5, Panel C). No bands are observed in reactions 
containing the TPI specific primers but no reverse transcriptase (Fig. 4.5, Panel D), 
confirming that no contaminating genomic DNA was present. Also, no bands were present 
in reactions where no cDNA was added, confirming no unspecific reactions had occured 
(Fig. 4.5, Panels A, B and C, lane 8).
4.3.6 : Immunoblot analysis of soluble extracts and ES products
Protein extracts from various stages of the schistosome life cycle were analysed by 
immunoblotting using anti-bSmCLl or anti-bSmCL2 sera as probes. In the case of 
SmCLl, a protein was observed at 33 kDa in male and female adults (Fig 4.6, panel A, 
lanes 1 and 2) which seemed to correspond to the mature enzyme. This protein was 
present at approximately double the amount in females as opposed to males. A band at 43 
kDa was also observed in males, females and cercariae (Fig. 4.6, panel A, lane 3) which 
may represent the pro-SmCLl. Various intermediate bands were also present which could
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be breakdown products of the pro-enzyme or differentially glycosylated forms of the 
enzyme. A strongly staining band at 33 kDa was also observed in adult worm ES 
products, indicating that SmCLl was secreted into the culture medium.
SmCL2 was also observed in male and female adult schistosomes (Fig. 4.6, panel 
B, lanes 1 and 2), although the mature form of 32 kDa was present in females at 
approximately five times the amount as that observed in males. An apparent pro-enzyme 
at 39 kDa was also observed in males and females. SmCL2 was also present in ES, but in 
comparatively lower amounts than SmCLl (Fig. 4.6, panel B, lane 4).
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Fig. 4.5 : RT-PCR analysis of SmCLl and SmCL2 expression in life-cycle stages of 
S. mansoni.
Mixed-sex adults (lane 1), male adults (lane 2), female adults (lane 3), eggs (lane 4), 
miracidiae (lane 5) and cercariae (lane 6) were analysed for the presence of mRNA 
encoding for SmCLl (Panel A) or SmCL2 (Panel B) by RT-PCR. SmCLl (Panel A, lane 
7) and SmCL2 (Panel B, lane 7) cDNAs were used as positive template controls. Control 
reactions with no added template DNA were also included (lane 8, all Panels). RT-PCRs 
using primers that anneal to cDNA of the constitutively-produced triosephosphate 
isomerase (TPI) were performed as a positive control (Panel C) while Panel D designates 
the control PCR reaction carried out using a blank reverse transcriptase to check for 
contaminating genomic DNA.
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Fig. 4.6 : Immunoblot analysis of soluble extracts and ES products of S. mansoni for 
the presence of native SmCLl and SmCL2.
Soluble protein extracts of male worms (lanes 1), female worms (lane 2), cercariae (lane 
3), and ES products (lane 4) were transferred to nitrocellulose filters and probed with 
rabbit anti-bSmCLl (Panel A) or rabbit anti-bSmCL2 (Panel B). Replicate filters probed 
with control pre-immune sera did not exhibit any reactivity (not shown).
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Chapter 5
Discussion
5.1: Introduction
Proteinases can play many roles in host-parasite interactions. It is clear from examination 
of the life cycle of helminth parasites that proteinases perform key functions in their 
development. Indeed, it can be argued that the evolution and diversification of proteinases 
has contributed to the success of parasitic helminths. The main selection pressure that 
initiated the parasite-host relationship may have been the ease by which nutrients could be 
acquired from the host by the parasite (Halton, 1987) and hence it is found that much of 
the predominant proteolytic activity in helminth parasites is involved in this function. 
However, the development of mechanisms to facilitate the parasites migration through the 
host tissue, to defend against host immunological attack, and to otherwise ensure the 
completion of their life cycle would obviously have presented other selection pressures. It 
is not unlikely that the diversification and specialisation of proteinases has played a major 
role in the development of these processes.
Schistosomes acquire their amino acid nutrients by degrading host haemoglobin 
and several proteinases have been implicated to be involved in this process. The 
dominance of cathepsin L activity in extracts of schistosome tissues and in ES products of 
adult worms (Dalton et al., 1996a) suggest that these enzymes (along with other 
proteinases) may be centrally involved in this mechanism. Indeed, inhibitors of cysteine 
proteinases were shown to prevent haemoglobin digestion by schistosomula and decrease 
their viability in vitro (Wasilewski et al., 1996; Zerda et a l,  1988). Moreover, treatment 
of S. mansoni-infected mice with these inhibitors not only reduced worm burden but 
delivered anti-fecundity affects, i.e. reduced egg output by females (Wasilewski et a l,
1996). Cysteine proteinases, including cathepsin L-like proteinases, are therefore
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considered important targets to which novel anti-schistosome chemotherapy and/or 
immunoprophylaxis could be directed.
Elucidation of the precise physiological role of proteinases of schistosomes has 
been hampered by the difficulty in obtaining homogenous enzymes. It is not practical to 
isolate the enzymes directly from schistosomes given the difficulty in obtaining large 
numbers of the parasites. Furthermore, many of the enzymes have similar molecular sizes 
and substrate specificity’s (for example, the cathepsin LI, cathepsin L2, cathepsin B and 
cathepsin C proteinases). In order to study the biochemical properties of these proteinases 
of S. mansoni it is therefore necessary to develop means by which the recombinant 
molecules can be expressed and purified in a functional form.
Several cysteine proteinases have been expressed in bacterial systems. However 
proteins overexpressed in E. coli frequently form insoluble aggregates or inclusion bodies 
in the bacterial cytoplasm (Kopitar et al, 1996; Smith and Gottesman, 1989; Taylor et al., 
1992; Kuhelj et al., 1995; Valesco et al; 1994; Dolinar et al; 1995). This is due to the 
absence of mechanisms for post-translational modification of the recombinant enzyme, 
resulting in an improperly folded product. Bacterial cells also lack secretion mechanisms 
present in eukaryotic cells causing build up of recombinant proteins within the cell 
cytoplasm. Recombinant cysteine proteinases expressed in bacteria aggregated in inclusion 
bodies and could only be solubilised by strong dénaturants in the presence of a reducing 
agent (Kopitar et al, 1996; Smith and Gottesman, 1989; Taylor et al., 1992; Kuhelj et al., 
1995; Valesco et al; 1994; Dolinar et al; 1995). Solubilised proteins were then refolded 
and the propeptide cleaved from the proenzyme by either auto-activation or addition of a 
second proteinase (e.g. pepsin or subtilisin) to yield the mature, active zymogen.
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In order to circumvent the problems of solubility and improper folding experienced 
with bacterial expression systems, various mammalian and insect cell systems have been 
employed to express recombinant cysteine proteinases (Bromme et al., 1996; Gotz and 
Klinkert, 1993; Kane, 1993; Tao et al., 1994). While these systems expressed the 
recombinant proteinases in an active form, yields were generally much lower than those 
obtained in the bacterial systems. Also, these systems are much more complex, costly and 
laborious.
Yeast expression systems are a popular alternative to bacterial and mammalian 
systems for the production of functionally active heterologous proteinases. As a unicellular 
microorganism, yeast retains the advantages of bacterial systems in their ease of 
manipulation and growth. On the other hand, yeast cells exhibit many features of cell 
structures normally associated with higher organisms and a eukaryotic subcellular 
organisation capable of accurate post-translational processing and modification of 
complex recombinant proteins. Heterologous proteins can be directed into the secretory 
pathway in yeast which can be advantageous as it avoids the build-up of potentially toxic 
proteins in the cell. Moreover, the secretion of the protein offers purification advantages in 
that extraction of the recombinant protein from cells is not necessary and there are much 
fewer contaminating proteins present in the culture medium compared to the cell extract. 
Secretion is of particular relevance for the production of recombinant cysteine proteinases 
as disulphide bond formation occurs during passage through the endoplasmic reticulum 
and Golgi body (Schekman and Novic, 1982).
For these reasons, the bakers yeast Saccharomyces cerevisiae, strain DBY746, 
was used in this study to express SmCLl and SmCL2. This expression system has been
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successfully used to produce substantial quantities of each of the two forms of cathepsin L 
from the related parasitic trematode Fasciola hepatica (Dowd et al., 1997; Roche et al.,
1997). Most importantly, in these cases the recombinant F. hepatica cathepsin Ls were 
secreted into the yeast culture medium in an active form, avoiding the need for activation 
steps.
5.2: Expression of SmCLl and SmCL2 in S. cerevisiae
Functional expression of recombinant proteins in yeast requires the recognition of 
trafficking signals within the cDNA (Moir and Davidow, 1991). In mammalian cells, 
cathepsin L proteinases are synthesised as preproenzymes that are sequentially processed 
to the mature molecules during their passage through the endoplasmic reticulum, Golgi 
complexes and lysosomes or secretory vesicles.
Proteins which enter the secretory pathway in eukaryotic cells have an amino- 
terminal signal peptide composed of 10-15 hydrophobic amino acid residues (Garoff,
1985; Kelly, 1985). Proteins containing these signal peptides, or pre-regions, are 
synthesised on ribosomes that are situated on the surface of the rough ER. The 
hydrophobic signal peptide is thought to embed into the lipid bilayer of the ER membrane 
while the rest of the protein is being synthesised (Rapoport, 1985). When the protein is 
fully synthesised, cleavage of the signal peptide by a specific signal peptidase releases the 
protein into the lumen of the ER, where the protein folds into its 3-dimensional 
conformation (Lodish, 1988). Most of the proteins containing this hydrophobic signal 
sequence will pass from the ER to the Golgi apparatus via transport vesicles.
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Proteins destined for secretion are packaged into secretory vesicles, which are 
formed by budding from the trans-Golgi network. The sorting signal which directs 
proteins into these vesicles is largely unknown, but it is thought to reside in the 
polypeptide chain of the protein (Griffiths and Simons, 1986). However, it has been 
suggested that motifs within the pro-peptide and also at the C-terminus of proteinases are 
involved in signalling proteinases into the secretory pathway. Mutations within the 
propeptide and deletion of C-terminal sequences of proPC2, a subtilisin-like serine 
proteinase, prevented its secretion from transfected mammalian cells (Taylor et al., 1997). 
It has also been suggested that proteins secreted from eukaryotic cells are transported by a 
non-selective “default pathway”; i.e. any protein in the ER will automatically be carried 
through the Golgi apparatus to the cell surface unless it is selected for transport elsewhere 
(Rothman, 1987).
Many lysosomal proteins are synthesised with N-terminal extensions, or 
propeptides, that are removed during or soon after delivery to lysosomes. In the case of 
mammalian cathepsin L and other cathepsins, one function of the propeptide is to regulate 
the enzymatic activity of the protein, rendering the protein inactive when it is present 
(Mason et al., 1989). The proregion of mammalian cathepsin L is also required for proper 
folding, stability and exit from the ER (Tao et al., 1994).
cDNAs encoding two distinct cathepsin L proteinases from S. mansoni and their 
homologues in S. japonicum  have been isolated (Smith et al., 1994; Michel et al., 1995; 
Day et al., 1995). Examination of the primary amino acid sequence of these cathepsin Ls 
revealed that these enzymes are synthesised as prepro-enzymes and would seem to possess
99
structures similar to those observed for the mammalian enzymes (Smith et al., 1994, 
Michel et al., 1995, Day et al., 1995; Dalton et al., 1996a).
The cathepsin L proteinases from the parasitic trematode F. hepatica were 
localised to secretory vesicles of the gut epithelial cells, indicating that these enzymes may 
be directed into the secretory pathway in these cells (Smith et al., 1993; Dowd et al., 
1994). Moreover, these molecules were also shown to be the major proteolytic activity 
present in culture medium in which these worms were incubated. Cathepsin L like activity 
has been also shown to be present in culture medium in which adult S. mansoni worms 
were incubated (Dalton et a l,  1996a), suggesting that one or both of the S. mansoni 
cathepsin Ls may also enter the secretory pathway in schistosome cells.
In this study, yeast cells were transformed with an expression plasmid p AAH5 
containing the cDNAs encoding the full-length pre-procathepsin SmCLl or SmCL2. 
Analysis of the culture supernatants harvested from cells transformed with SmCLl or 
SmCL2 indicated that cathepsin L-like activity was secreted into the culture medium in 
both cases. This suggests that both proteinases are trafficked through the normal secretory 
pathway in yeast and that the preproenzymes contain all the information necessary for 
processing and secretion. Similar results were observed for the functional expression of 
Fasciola hepatica pre-procathepsin Ls expressed in the same yeast system as that used to 
express SmCLl and SmCL2 (Dowd et al., 1997; Roche et al., 1997). Indeed, expression 
of.F. hepatica cathepsin LI in secretion-defective yeast mutant strains verified that this 
enzyme was secreted through the normal secretory pathway and not through a non­
specific pathway or by leakage from the cell (Roche et a l,  1997).
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There have been several previous reports of the expression of cysteine proteinases 
in S. cerevisiae, including mammalian cathepsin B (Rowan et al., 1992), cathepsin S 
(Bromme et a l,  1993), papain (Vernet et a l,  1993) and S. mansoni cathepsin B (Lipps et 
a l,  1996). In all these cases the enzymes have been expressed as fusion proteins with the 
yeast a-factor pre- or pre-pro signals. It is noteworthy that these recombinant 
proteinases were secreted from the yeast as inactive proenzymes and have required a 
subsequent activation step to obtain functionally active enzyme (Rowan et a l, 1992; 
Bromme et a l,  1993; Vernet et a l,  1993; Lipps et a l,  1996). In the case of F. hepatica 
cathepsin Ls expressed in S. cerevisiae, the recombinant proteinases which were purified 
from the yeast culture medium were identical in molecular weight to the native enzymes, 
indicating that the recombinant proteinases were processed in the yeast cells in a similar 
fashion to the native proteinases (Dowd et a l,  1997; Roche et a l,  1997).
Studies on the processing of the pro-enzyme to the mature form of mammalian 
cathepsins indicate that an endoproteinase(s) is involved in the initial cleavage of the pro­
peptide and that the final processing steps are performed by exopeptidases that clip amino 
acids from the N-terminus of the molecule as far as the molecular structure of the mature 
enzyme will allow (Rowan et a l,  1992; Mach et a l, 1993; Isidoh and Kominami, 1994). 
These cleavages are thought to begin in the trans-Golgi network and they continue in the 
secretory vesicles.
Asparaginyl residues were shown to occur near the cleavage point between the 
pro-peptide and mature enzymes of cathepsin LI, cathepsin L2, cathepsin B, cathepsin D 
and cathepsin C of schistosomes (Dalton and Brindley, 1996, 1997). This observation led 
these authors to propose that a novel cysteine proteinase, an asparaginyl endopeptidase
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termed schistosome legumain (also known as Sm32) was the endoproteolytic activity 
involved in the cleavage of the pro-peptide from the mature protein of these proteinases. 
Asparaginyl residues are also present in the vicinity of the cleavage point between the pro­
region and mature protein of F. hepatica cathepsin LI and L2, and this parasite also 
expresses an asparaginyl endopeptidase (Dowd and Dalton, unpublished data). These 
observations suggest that trematodes possess a common mechanism, involving 
asparaginyl endopeptidases, for the processing of cathepsin proteinases. In addition, since 
mammalian cathepsins do not contain these asparagine residues close to the cleavage point 
of their pro-regions, these enzymes likely undergo different processing to the trematode 
cathepsins.
A recent entry into the public databases (Genbank accession number U32517) 
revealed that S. cerevisiae possesses a putative asparaginyl endopeptidase. If this enzyme 
is involved in the maturation of secreted proteinases, it may explain why ySmCL l and 
ySmCL2 are processed to their active form in yeast. It is noteworthy that S. mansoni 
cathepsin B expressed in S. cerevisiae was secreted as an inactive pro-form, unlike 
ySmCLl and ySmCL2 (Lipps et al., 1996). However, SmCLl and SmCL2 were 
expressed utilising their native pre-region as a signal sequence, whereas the cathepsin B 
was expressed as a fusion protein, where the pro-cathepsin B was fused to yeast a-factor 
secretion signal. It is possible that the cathepsin B fusion protein was processed in a 
different fashion to prepro-ySmCLl and prepro-ySmCL2. The a-factor signal may have 
targeted the protein differently to its native pre-region and the protein may not have been 
exposed to the action of the asparaginyl endopeptidase.
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Both in the case of ySmCLl and ySmCL2, yields of recombinant protein secreted 
into the culture medium were quite low in comparison to yields obtained for the 
expression of other recombinant cathepsins. There are a number of reasons which may 
explain why such poor yields were obtained. Firstly, the pAAH5 expression vector utilises 
the constitutive, glycolytic alcohol dehydrogenase (ADH 1) promoter of S. cerevisiae. 
Glycolytic promoters are most active at the start of fermentation, when the sugar 
concentration is highest. This can result in the production a recombinant protein which is 
toxic to the cell which can hinder cell growth and produce a selective pressure for a 
reduction in expression. Secondly, both ySmCLl and ySmCL2 were processed to their 
active form in yeast, and it is possible that in this form, the enzymes may have been toxic 
to the yeast cell. Thirdly, as ySmCLl was glycosylated by the yeast cells (discussed in 
section 5.3), glycosylation of the protein may have been a rate limiting step in the 
secretion of the protein, thereby reducing levels of expression. Finally, as pAAH5 is an 
autonomously replicating plasmid, it was necessary to grow the transformed yeast in 
selective medium. Selection pressure must be retained throughout growth otherwise the 
yeast cells can lose their plasmids. However, growth in selective medium resulted in low 
levels of biomass accumulation and correspondingly low levels of expression.
Attempts by Lipps et al. (1996) to express cathepsin B in S. cerevisiae using the 
constitutive a-factor promoter also resulted in low yields of recombinant protein 
(approximately 20 pg of recombinant protein per liter of culture). However, in this same 
report, high levels of expression (up to 10 mg/liter of culture) were achieved when the 
enzyme was expressed the under the control of a galactose-inducible promoter. The use of 
inducible promoters allows high cell numbers to be achieved before expression of the
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recombinant protein is induced, and any deleterious effects of the recombinant protein on 
cell growth are avoided. The recombinant cathepsin B was also produced and secreted in 
its inactive pro-form, which is unlikely to be as toxic to the yeast cell as the mature, active 
product. Furthermore, the cloned cDNA encoding the cathepsin B was mutated to delete a 
potential glycosylation site. Expression of SmCLl and SmCL2 using a similar system to 
that described for cathepsin B may increase yields of these proteinases significantly.
Alternatively, systems other than S. cerevisiae for expression of SmCLl and 
SmCL2 could be investigated. In recent times, a number of non-Saccharomyces yeast 
strains have emerged as hosts for recombinant protein production. Human cathepsin L has 
been expressed in the methylotropic yeast Pichia pastoris and yields of 20 mg of 
recombinant enzyme per litre of culture were obtained, which were sufficient for 
crystallisation studies to be performed on this molecule (Coulombe et al., 1996a, 1996b). 
Furthermore, P. pastoris expression systems allow the expression cassette to be integrated 
into the yeast genome, thereby avoiding stability problems associated with autonomously 
replicating plasmids and allowing growth in complete, non-selective medium. This allows 
much higher biomass levels to be obtained compared to growth in selective medium, with 
correspondingly higher levels of expression of the recombinant protein.
Various bacterial expression systems have been used to express cathepsin 
proteinases as described earlier, and although the proteins have been expressed in 
denatured form in insoluble inclusion bodies, many of the enzymes have been solubilised 
and refolded to yield active product. While only a small percentage of the denatured 
protein is recovered in active form (e.g. Smith and Gottesman (1989) reported less than 
0.1% of the total recombinant human cathepsin L produced in E. coli was recovered
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actively), the expression levels in bacterial systems are so high that the yield of renatured 
active proteinase is usually comparable with that obtained in yeast and mammalian
systems.
5.3: Purification of recombinant cathepsin Ls
The recombinant ySmCLl and ySmCL2 were purified from the yeast culture medium 
using conventional chromatography techniques. ySmCLl was purified by gel-filtration 
followed by anion exchange chromatography. Z-Phe-Arg-NHMec-cleaving activity eluted 
from the gel-filtration column as two peaks, the second peak being used for subsequent 
purification as it contained proteinase with higher specific activity. Similar elution profiles 
from gel filtration were observed for the purification of recombinant Fasciola hepatica 
cathepsin Ls expressed in yeast (Dowd et al., 1997; Roche et al., 1997). It is possible that 
the elution of the enzymes in two peaks may be due to aggregation of some of the 
recombinant enzyme to yeast proteins.
ySmCLl was further purified on an anion exchange column. The major 
proportion of the proteolytic activity did not bind to the resin at pH 7.0, but was collected 
in the run-through fractions. This was unexpected as SmCLl, with a predicted isoelectric 
point (pi) of 5.6, would be expected to have an overall negative charge at pH 7.0 and 
hence bind to an anion exchanger. It is possible, however, that the true pi of SmCLl is 
higher than the value predicted from the primary sequence as pi values of native proteins 
are determined by the charges of the amino acid residues that are exposed on the outer 
surface of the molecule. Nevertheless, while the ySmCLl did not bind to the resin, the 
majority of the contaminating yeast proteins did bind and hence the y SmCLl was further
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purified. In fact, it was probably advantageous that ySmCLl did not bind to the anion 
exchanger as elution conditions from ion exchange columns can decrease enzyme activity, 
especially if proteins bind tightly and harsh elution conditions are required to remove them 
from the resin.
Peaks containing cathepsin L activity were analysed by SDS-PAGE and 
immunoblotting using anti serum prepared against bacterially-expressed SmCLl (anti- 
bSmCLl serum). A protein was observed to be enriched as a result of the purification and 
this protein was highly reactive with anti-bSmCLl serum, verifying its identity as the 
recombinant SmCLl. This protein migrated at approximately 45 kDa on gels, which is 
larger than the predicted size for the mature SmCLl (24 1) or the proenzyme (35 kDa). 
Examination of the primary amino acid sequence of SmCLl reveals that this proteinase 
contains three potential N-linked glycosylation sites in its mature region. Probing of the 
purified ySmCLl for the presence of N-linked sugar residues revealed that the enzyme 
was indeed glycosylated and this may explain why it migrates higher than the expected size 
on gels. Immunoblot analysis of crude schistosome extracts indicated the presence of a 33 
kDa protein and a 43 kDa protein, seemingly representing the mature-SmCLl and pro- 
SmCLl respectively (Fig. 4.6). The molecular sizes observed for the native enzyme would 
suggest it too may be glycosylated.
N-linked glycosylation occurs in the lumen of the ER in mammalian cells. The 
transfer of a core oligosaccharide (composed of N-acetyl-glucosamine, mannose and 
glucose and containing a total of 14 sugar residues) is transferred to target asparagine 
residues in a single enzymatic step almost as soon as the residue emerges in the ER lumen 
during protein synthesis on the ribosome (Hirschberg and Snider, 1987). Glycoproteins are
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transferred from the ER via transfer vesicles to the Golgi body, where the oligosaccharide 
chains are ‘trimmed’ in the lumen of the Golgi. The purpose of N-linked glycosylation of 
glycoproteins, however, remains unknown. It was originally thought that N-linked 
oligosaccharides functioned in transport of glycoproteins through the ER and Golgi, 
although this now does not seem to be the case (Stanley, 1987). Indeed, most proteins 
retain their normal activities in the absence of glycosylation (Stanley, 1987). However, it is 
known that acid hydrolases destined for trafficking to lysosomes carry mannose 6- 
phosphate (M6P) groups which are added exclusively to the N-linked oligosaccharides of 
these enzymes in the Golgi (Pfeifer, 1988). Since all glycoproteins arrive in the Golgi with 
identical N-linked oligosaccharide chains, the signal for adding M6P units to 
oligosaccharides resides somewhere in the polypeptide chain of each protein (Lang et a l,  
1984). The nature of this recognition sequence is still not known.
Yeast cells tend to hyperglycosylate glycoproteins in comparison to mammalian 
cells. The average length of oligosaccharide chains of glycoproteins from S. cerevisiae is 
40 mannose residues, in comparison to 8-14 residues added by mammalian cells 
(Tarentino et a l,  1974). This would correlate with the molecular sizes observed for the 
ySmCLl (45 kDa) and the native enzyme (33 kDa) expressed in schistosome tissues and 
may explain why the former molecule migrates higher than its predicted size on SDS- 
PAGE gels.
Modification of the N-linked glycosylation motif -Asn-X-Ser- (where X is any 
amino acid except proline) in the protein using site directed mutagenesis results in absence 
of glycosylation. This approach was adopted for expression of rat cathepsin B (Hasnain et 
a l,  1993), human cathepsin L (Kane, 1993) and S. mansoni cathepsin B (Lipps et al.,
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1996) as it has been postulated that hyperglycosylation by yeast may result in an inactive 
enzyme. These proteinases were expressed and secreted as pro-enzymes, whereas 
ySmCLl was secreted seemingly in its activated, mature form. Neither of the F. hepatica 
cathepsin Ls contain glycosylation motifs in their primary sequences (Roche et al., 1997) 
and both of these recombinant proteinases were secreted as mature enzymes using the 
same expression system employed for expression of SmCLl. It is not clear how 
glycosylation (or the absence of glycosylation) affects the processing, targeting and 
functionality of these enzymes. However, hyperglycosylation did not seem to adversely 
affect the activity and secretion of ySmCLl.
ySmCL2 was purified from the culture medium using two gel-filtration columns 
with different separation ranges. When total culture supernatant was applied to the first 
gel filtration column, ySmCL2 resolved as two peaks similar to the profile observed for 
ySmCLl. Again, it is suggested to be due to a portion of the recombinant enzyme 
aggregating to yeast proteins. As described for ySmCLl, the second peak of activity was 
used for subsequent purification as it contained the higher specific activity. It was 
attempted to further purify ySmCL2 on ion exchange resins, however, it was found that 
no cathepsin L activity was recovered from either anion or cation exchange resins. The 
reason for this is unclear. Nonetheless, a second gel filtration column was employed 
instead of an ion exchanger and enzyme activity was eluted after the main protein peak on 
this column.
Analysis of the purified ySmCL2 by SDS-PAGE revealed that a protein of 
approximately 32 kDa had been purified close to homogeneity in fractions containing 
cathepsin L activity. This protein was also reactive with antiserum prepared against
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bacterially-expressed SmCL2 (anti-bSmCL2 serum) on immunoblots, verifying its identity 
as the recombinant proteinase. This immunoreactive 32 kDa protein was also apparent in 
the unpurified crude concentrated supernatant from the fermentation and in the pool from 
the first gel filtration (S300 HR) column. Two additional proteins of approximately 38-40 
kDa were also observed to react with the serum in both these lanes. The larger protein of 
approximately 40 kDa would seem to correspond to the pro-ySmCL2, whereas the protein 
at approximately 38 kDa may represent a semi-processed form of the pro-enzyme. Neither 
of these proteins were observed in the pool collected from the second gel-filtration 
(Superose 12) column, indicating that the mature enzyme was separated from the pro­
enzyme in this step.
A protein of 32 kDa in size also reacted with anti-bSmCL2 in S. mansoni crude 
worm extract, although the predicted molecular mass of the mature SmCL2 is 24.3 kDa. 
However a protein of 32 kDa in size was also observed by Michel et al. (1995) to react 
with anti-SmCL2 serum in schistosome extracts, and they concluded that this protein 
represented mature SmCL2. They postulated that the protein may have an anomalous 
behaviour on SDS-polyacrylamide gels or that the proteinase could be glycosylated, as the 
proposed amino-acid sequence of the mature protein indicates the presence of one 
potential N-linked glycosylation site. However, expression of the mature SmCL2 in E. 
coli, which lacks the machinery for glycosylation of proteins, also resulted in a expression 
of a protein of approximately 32 kDa (Figs 4.1 and 4.2). This suggests that both the native 
enzyme and the yeast-expressed recombinant protein are not modified by glycosylation but 
do indeed run anomalously on SDS-PAGE gels. While SmCL2 does possess a single 
potential N-linked glycosylation site, examination of the deduced amino acid sequence of
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SmCL2 shows that this site lies at Asn-204, in close proximity to the S2  subsite Ala-205, 
and would, therefore, be unlikely to be exposed to the glycosylation machinery of the cell 
(Dalton et a l , 1996a).
While both ySmCLl and ySmCL2 were purified close to homogeneity, substantial 
losses of enzyme were incurred during the purification of both proteinases. As explained 
earlier, a large proportion of each enzyme was lost due to the fact that both proteinases 
seperated as two peaks on the first gel filtration column. Losses of activity were also 
incurred in concentration steps performed between the stages of purification. It is likely 
that higher yields of enzyme would have been achieved if a one step, affinity-based 
purification scheme had been employed instead of gel filtration and ion exchange 
chromatography. A hexa-histidine affinity tag was engineered onto the carboxy-terminus 
of S. mansoni cathepsin B expressed in S. cerevisiae, and this enzyme was purified to 
homogeneity by elution from nickel chelte resin (Lipps et a l,  1996). The hexa-His tag did 
not seem to adversely affect the activity of the enzyme. One step purification of human 
cathepsin D was achieved by affinity chromatography using immobilised propeptide 
sequences (Wittlin et a l,  1998). The propeptides of cathepsin proteinases are known to 
bind their respective mature enzymes highly specifically and Wittlin et a l (1998) 
suggested that a similar strategy as that employed for the purification of cathepsin D could 
also be utilised for the simple, one-step purification of other families of proteinases.
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The Si subsite in the active site of cysteine proteinases is involved in the interaction with 
the Pi site of the substrate, the formation of the transition states and the catalytic cleavage 
of the peptide bond. Interactions between the amino acids of the enzyme S2 sub site and 
the residue in the P2  position of the substrate determine the specificity of cysteine 
proteinases (Barrett and Kirschke. 1981). While analysis of the amino acid sequences in 
the mature region of SmCLl and SmCL2 reveals that the two proteinases have only 
43.8% identity (Dalton et al., 1996a), the residues which constitute the active site of the 
enzymes are very similar. The Si subsite is highly conserved in cysteine proteinases, and 
this site is virtually identical between SmCLl and SmCL2 (Fig. 5.1). The residues 
constituting the S2 subsite of SmCLl and SmCL2 are also very similar (Fig. 5.1) and the 
hydrophobic character of the residues forming this site is well conserved amongst the 
cathepsin L class. However, discrete differences are evident, which may account for 
different interactions with the substrate. In an effort to identify differences in the substrate 
specificity of SmCLl and SmCL2, a panel of synthetic fluorogenic peptides of varying 
amino acids in the Pi and P2  positions were investigated as potential substrates for the 
purified, yeast-expressed ySmCLl and ySmCL2 proteinases.
Mammalian cathepsin Ls have been shown to have a high affinity for the peptide 
substrate Z-Phe-Arg-NHMec and this substrate has classically been used to identify and 
characterise cathepsin L-like activities (Barrett and Kirschke, 1981; Mason et al., 1985). 
Both ySmCLl and ySmCL2 have a high affinity for Z-Phe-Arg-NHMec (kcat/Km = 38.86 
m M 's'1 & 406.3 mM'1s'1 respectively), and show little or no affinity for Z-Arg-Arg-
5.4: Biochemical characterisation of ySmCLl and ySmCL2
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Fig 5.1. Schematic diagram of the amino acid residues which constitute the substrate 
binding pockets (Si, S2 and S3 sites) of SmCLl and SmCL2. ‘*5 denotes residues of the 
catalytic triad involved in cleavage of the scissile bond. The numbering of amino acids is 
based on the papain system of Drenth et al. (1971). Homology modelling of the active 
sites was performed in collaboration with Dr. Ross Brinkworth, Centre for Drug Design, 
University of Queensland, Australia.
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NHMec (kcat/Km =1.10 n M 's '1 for ySmCLl and no cleavage observed for ySmCL2), a 
substrate which is cleaved by cathepsin B-like enzymes. Cathepsin B-like proteinases 
contain a negatively-charged glutamate at the bottom of their S2 subsite pocket, which 
favours the binding of basic P2 residues like arginine. By contrast, the S2 subsite of 
cathepsin Ls are generally very hydrophobic and open, which explains a specificity for the 
bulky aromatic side-chain of phenylalanine.
ySmCL2 shows a particularly high affinity for Z-Phe-Arg-NHMec (kcat/Km = 406.3 
mM'V1), displaying over ten times higher affinity for this substrate in comparison to 
ySmCLl. SmCL2 shows higher homology to mammalian cathepsin Ls in comparison to 
SmCLl, both in its primary amino acid sequence and in the amino acids which make up 
the subsites of the active site (Dalton et al., 1996a). Examination of the composition of the 
S2 subsite of SmCLl reveals that it is composed completely of hydrophobic amino acids, 
three of which are aliphatic (Leu 67, Leu 159, Val 208), whereas the S2 subsite of SmCL2 
is mainly composed of hydrophobic residues, with a hydrophilic end in the form of Asn 
209. These differences would suggest that SmCLl may bind aliphatic residues more 
efficiently in the P2 position whereas SmCL2 may prefer aromatic residues, such as 
phenylalanine. Support for this hypothesis comes from a comparison of the affinities of 
ySmCLl and ySmCL2 for Boc-Val-Leu-Lys-NHMec, relative to their affinities for Z-Phe- 
Arg-NHMec. Both enzymes show similar affinities for Boc-Val-Leu-Lys-NHMec (kcat/Km 
= 116.8 mM'V1 for ySmCLl and 147.5 mM'V1 forySmCL2). However, ySmCLl cleaves 
Boc-Val-Leu-Lys-NHMec with approximately three times higher efficiency than its 
cleavage of Z-Phe-Arg-NHMec (k^t/Km = 38.86 mM 'V1), while the opposite is true for 
ySmCL2 (kcat/Km = 406.3 m M 'V  for Z-Phe-Arg-NHMec). It would seem that ySmCLl
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has a preference for the aliphatic leucine over the aromatic phenylalanine in the P2  
position.
A preference for Boc-Val-Leu-Lys-NHMec over Z-Phe-Arg-NHMec has also been 
observed for cathepsins LI and L2 of F. hepatica (Dowd et al., 1994, 1997; Roche et al.,
1997). Other cathepsin L-like cysteine proteinases such as the acid cysteine proteinase and 
the neutral thiol proteinase from the trematode parasite Paragonimus westermani 
(Yamakami and Hamajima, 1990; Yamakami et al., 1995) and the acid-activatable 
cysteine proteinase of the cellular slime mould Dictyostelium discoideum (North et al., 
1996) also showed a marked preference for Boc-Val-Leu-Lys-NHMec. Boc-Val-Leu- 
Arg-NHMec, a substrate very similar to Boc-Val-Leu-Lys-NHMec, was cleaved much 
more efficiently than Z-Phe-Arg-NHMec by the cathepsin L-like cysteine proteinase 
(termed falcipain) from the malarial strain Plasmodium falciparum (Salas et al., 1995). 
Interestingly, analogous to the proposed role of SmCLl in schistosomes, falcipain has 
also been implicated to be involved in host haemoglobin digestion by malaria parasites. 
While Boc-Val-Leu-Lys-NHMec has been used as a substrate for chymotrypsin, there are 
no known reports of this peptide being used as substrate for mammalian cathepsin Ls. 
However, this substrate was shown to be cleaved by human osteoclast cathepsin K with 
four times less efficiency than Z-Phe-Arg-NHMec (Bossard et a l,  1996). It is tempting to 
speculate that Boc-Val-Leu-Lys-NHMec could potentially represent a substrate that 
could distinguish parasite cathepsin Ls from their mammalian homologues. Such a 
distinction could provide possible leads into the design of inhibitors directed specifically 
against the active sites of the parasite cathepsin Ls, and could thus have potential as novel 
chemothereputic agents.
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Of the panel of substrates examined, SmCL2 only cleaved Z-Phe-Arg-NHMec and 
Boc-Val-Leu-Lys-Nl IMec, while SmCLl cleaved a number of additional substrates. 
SmCLl demonstrated a particularly high affinity for H-Leu-Val-Tyr-NHMec and Suc- 
Leu-Tyr-NHMec, indeed cleaving these substrates more efficiently than Z-Phe-Arg- 
NHMec. This is not altogether surprising, as SmCLl would be expected to bind the 
aliphatic leucine and valine residues in the S2  pocket as argued earlier. However, it is 
surprising that SmCL2 did not cleave these substrates also, at least to a lesser degree than 
SmCLl. Since the Si pocket of SmCL2 is virtually identical to SmCLl, it should accept 
Tyr in the Pi position and its cleavage of Boc-Val-Leu-Lys-NHMec suggest that it can 
accept Leu in the P2 position. It is possible that SmCL2 will not tolerate succinyl groups at 
P3, although this is unlikely as the S3 pockets of both enzymes are also very similar. The 
reason why SmCL2 does not cleave these substrates as opposed to SmCLl is not clear, 
however, ongoing collaborative studies with Dr. Ross Brinkworth (University of 
Queensland, Australia) using computer modelling of the active sites of these proteinases 
may answer this enigma. These studies may show that the conformation of the active sites 
are influenced by other areas of the proteins keeping in mind that SmCLl and SmCL2 are 
only 43% similar in amino acid sequence.
Tos-Gly-Pro-Arg-NHMec was moderately cleaved by SmCLl, but not at all by 
SmCL2. This substrate is cleaved with high efficiency by Fasciola hepatica cathepsin L2, 
but not by F. hepatica cathepsin LI (Dowd et al., 1994). It was used to distinguish 
between the two forms of cathepsin L in this parasite and the authors postulated that the
F. hepatica cathepsin LI may have a more ‘open’ S2  pocket than F. hepatica cathepsin 
L2, thus allowing a bulky proline P2 residue to bind in the S2 pocket. Recent studies have
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demonstrated that the S2 pocket of SmCLl is more open than that of SmCL2 (Ross 
Brinkworth, personal communication) and this may accommodate a bulky side chain such 
as that of proline. However, the moderate activity shown by SmCLl for Tos-Gly-Pro- 
Arg-NHMec would indicate that the proline side chain may not fit into the S2 pocket very 
well, and cleavage of this substrate may be more a reflection of the affinity of the S3 site 
for glycine and the Si sites for arginine, rather than any specific affinity of the S2 subsite 
for proline. This idea is supported by the fact that the other substrates examined which 
contained proline in the P2 position (Tos-Gly-Pro-Lys-NHMec, Tos-Val-Pro-Arg- 
NHMec) were not cleaved at all by SmCLl.
The other substrates examined, Z-Phe-Ser-Arg-NHMec and Tos-Gly-Lys-Arg- 
NHMec and Tos-Leu-Gly-Arg-NHMec, were not cleaved by ySmCLl or ySmCL2. This 
was expected for the substrates Z-Phe-Ser-Arg-NHMec and Tos-Gly-Lys-Arg-NHMec 
because a polar serine residue and a positively charged lysine residue in the P2 position 
would not bind into the very hydrophobic S2 pocket. It may be surprising that Tos-Leu- 
Gly-Arg-NHMec was also not cleaved by either enzyme, as the hydrophobic glycine 
residue in the P2  position might have been expected to bind in the S2  pocket. However, 
molecular modelling studies reveal that this substrate simply would not have enough 
sidechain contacts (glycine only has a single hydrogen atom sidechain) to bind into the 
active site with sufficient affinity to be cleaved (Ross Brinkworth, personal 
communication).
In summary, it would appear that SmCLl favours substrates containing the 
following general m otif: aliphatic(P3 )-aliphatic(P2)-positive or polar hydrophobic(Pi), 
whereas SmCL2 may favour aliphatic(P3)-aromatic(P2)-positive(Pi). However, further
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kinetic analysis with a larger panel of substrates coupled with further computer modelling 
of the active sites is required to fully understand the substrate specificity’s, the makeup 
and structure of the active sites of these enzymes and to identify substrates which may 
have optimal binding energy.
The substrate specificities observed for ySmCLl and ySmCL2 display distinct 
similarities with activities observed by Dalton et al. (1996a) in crude extracts and ES 
products of adult schistosomes. High levels of Z-Phe-Arg-NHMec cleavage were 
observed in soluble extracts of adult S. mansoni, both at pH 4.5 and pH 6.5 and this 
cleavage was attributed to be due to cathepsin L activity. This would seem to be the case 
as ySmCLl, and particularly ySmCL2, efficiently cleave Z-Phe-Arg-NHMec (Fig. 4.2). 
Indeed, a pH profile of Z-Phe-Arg-NHMec-cleaving activity in S. mansoni extracts shows 
the presence of what appears to be two distinct peaks of activity (Dalton et al., 1996a). 
pH profiles of ySmCLl and ySmCL2 against Z-Phe-Arg-NHMec show that ySmCLl has 
a broad pH profile, peaking at pH 6.5, whereas ySmCL2 had a much narrower range of 
activity, peaking at pH 5.5. The two peaks of Z-Phe-Arg-NHMec-cleaving activity 
observed in S. mansoni extracts may, therefore, correspond to a combination of SmCLl 
and SmCL2, with SmCLl cleavage occurring over a broad pH range and SmCL2 cleavage 
occurring below pH 6.0. Cathepsin B in schistosome extracts may also contribute to the 
cleavage of Z-Phe-Arg-NHMec at pH 6.5 (Dalton et al., 1996a), although it has been 
shown that recombinant S. mansoni cathepsin B does not cleave Z-Phe-Arg-NHMec very 
efficiently (Lipps et al., 1996).
Cleavage of Boc-Val-Leu-Lys-NHMec was also observed in extracts of S. 
mansoni, although levels of cleavage of this substrate were over 50% lower than levels
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observed for Z-Phe-Arg-NHMec (Dalton et al., 1996a). Boc-Val-Leu-Lys-NHMec is a 
substrate which has been used to detect chymotrypsin-like activity. However, in the 
studies performed by Dalton et al. (1996a), activity against other chymotrypsin substrates 
was not observed. Furthermore, the Boc-Val-Leu-Lys-NHMec-cleaving activity was 
enhanced in reducing conditions characteristic of cleavage by a cysteine proteinase and 
these results led the authors to conclude that this cleavage to be due to a cathepsin L-like 
proteinase(s). This would, again, appear to be the case as both ySmCLl and ySmCL2 
efficiently cleave this substrate. Levels of cleavage of Boc-Val-Leu-Lys-NHMec were 
higher at pH 6.5 than at pH 4.5 in S. mansoni extracts and it is likely that this cleavage is 
due to SmCLl as ySmCL2 is virtually inactive above this pH.
Examination of the pH profiles of the recombinant proteinases may also provide 
some clues into the possible functions of SmCLl and SmCL2. ySmCLl exhibited a broad 
bell-shaped activity profile against Z-Phe-Arg-NHMec, with an optimum activity at pH
6.5. The enzyme retained over 50% of its activity at pH 4.5 and at pH 8.0. Fasciola 
hepatica cathepsin LI is also stable over a broad pH range, in contrast to human cathepsin 
L which is completely inactivated above pH 7.0 (Dowd et al., submitted 1998). The 
instability of the mammalian cathepsin L at neutral pH has been proposed as one of the 
mechanisms by which mammalian cells are protected against accidental proteolysis by 
enzyme which may leak from the lysosomes (Mason et al., 1985). The apparent stability 
of F. hepatica cathepsin LI over a wide pH range is thought to be essential in order for 
this enzyme to perform its diverse biological functions, which include immune evasion, 
tissue penetration and blood feeding. Likewise, the stability of ySmCLl over a broad pH 
range may indicate that SmCLl may have a number of diverse functions or that the
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enzyme may have to tolerate different physico-chemical environments. By contrast, 
ySmCL2 was not active above pH 6.5, and was more active in acidic conditions, 
characteristics similar to mammalian cathepsins indicating that SmCL2 may have a more 
defined function.
Summing up, it would appear that SmCLl is active over a broader pH range and 
has the ability to cleave a broader range of substrates in comparison to SmCL2. Such 
observations may be manifested in the biological functions of these enzymes and is also 
further evidence that the two enzymes perform quite different functions.
5.5: Expression of SmCLl and SmCL2 in schistosomes
It is thought that from a limited set of ancestral enzymes a complex series of proteinases 
evolved by a process of gene duplication and divergence. Subsequent to this divergence, 
the enzymes would have acquired a higher degree of specificity by tailoring their catalysis 
to a discrete suite of peptide bonds located at specific sites in protein substrates. At the 
same time, the expression and distribution of these new proteinases could also be 
restricted, generating proteinases for specific purposes and located in specific tissues 
(Neurath, 1984; Creighton and Darby, 1989). By determining the stage(s) or site(s) of 
expression of these enzymes, we may get further insights into the function of the 
proteinase. The expression of SmCLl and SmCL2 in the life-cycle stages of S. mansoni 
was examined by RT-PCR and western blotting using anti-sera prepared against the 
recombinant proteinases expressed in E. coli.
RT-PCR analysis revealed that mRNA encoding for SmCLl and SmCL2 was 
present in both male and female adult worms. This was expected, as the cDNAs encoding
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for both of these proteinases were originally isolated from adult cDNA libraries (Smith et 
a l,  1994; Michel eta l., 1995). mRNA encoding for SmCLl was also detected in 
cercariae, but not in eggs or miracidia, while SmCL2 was not detected in any of the larval 
stages. Z-Phe-Arg-NHMec-cleaving activity has been previously detected in extracts of 
schistosome eggs and miracidiae (Day et a l,  1995; Yoshino et a l, 1993), however, it 
would appear that this cleavage is not due to SmCLl or SmCL2. Since most cDNA 
libraries are constructed from the mRNA isolated from adult schistosomes, it is possible 
that there are other as yet undiscovered cathepsin L-like cysteine proteinases expressed in 
these other stages of the schistosomes life cycle.
Z-Phe-Arg-NHMec-cleaving activity, with a pH optimum of 6.2, has been 
detected in extracts of S. mansoni cercariae (Dalton e ta l ,  1995a). Boc-Val-Leu-Lys- 
NHMec cleavage was also observed in cercarial extracts, although at much lower levels 
than Z-Phe-Arg-NHMec cleavage. mRNA encoding for SmCLl was detected in cercariae 
and a band of 43 kDa, which seems to correspond to pro-SmCLl, was reactive on 
immunoblots with anti-bSmCLl serum. This would suggest that SmCLl is not responsible 
for the Z-Phe-Arg-NHMec-cleaving activities observed in cercarial extracts. However, it 
is possible that pro-SmCLl may have been processed to an active, mature form during the 
preparation of the schistosome extract or the during the thirty mins of the enzyme assay. 
Additionally, or alternatively, cercariae may express an as yet undiscovered cathepsin L- 
like proteinase other than SmCLl or SmCL2.
Indeed, the presence of the pro-SmCLl in cercariae instead of the processed, 
mature form of SmCLl would indicate that this enzyme may not be active at all in this 
stage. It is possible that SmCLl is being stored in cercariae as the inactive pro-form in
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order for its processing and activation at a later stage in development. SmCLl has been 
implicated in the degradation of haemoglobin by schistosomes (Dalton et a l ,  1996a and 
this thesis) and it known that the nascent digestive tract of the schistosome becomes active 
within hours following cercarial transformation into schistosomula after tissue penetration 
of the primary host occurs. Furthermore, in vitro, erythrocytes are ingested by 
schistosomula within days of transformation (Basch, 1981). Therefore, the reason for the 
expression of the inactive pro-form of SmCLl in cercariae may be to ensure that the 
parasite has the digestive machinery in place in preparation for feeding once the skin is 
penetrated. Cathepsin L-like activity has been detected in developing schistosomula 
(Dalton et al., 1995a), and this may be due to SmCLl.
The predicted size of mature SmCLl from its deduced primary amino acid 
sequence is 24.1 kDa (Smith et a l, 1994), however, the bands detected on immunoblots 
ranged from 33 to 43 kDa. As discussed earlier, the recombinant proteinase is 
glycosylated by yeast which would suggest that it may also be glycosylated in 
schistosomes and this may explain why the molecule migrates higher than its predicted size 
on gels. The 33 kDa band would, therefore, appear to represent the mature SmCLl while 
the 43 kDa protein would correspond to pro-SmCLl. A number of immunoreactive 
proteins were observed on blots at sizes ranging from 33 to 43 kDa may represent 
differentially processed zymogens of the pro-SmCLl molecule or degradative products of 
the molecule resulting from enzymatic cleavage by another proteinases(s) present in the 
extract. SmCL2 was observed as an apparent mature, processed form which migrated at 
32 kDa and a pro-enzyme at 39 kDa. As discussed earlier, while these sizes are higher 
than the predicted sizes deduced from the primary amino acid sequence of SmCL2 (Michel
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et. al., 1995), it appears that this proteinase is not glycosylated, but rather, runs 
anomolously on gels.
Immunoblot analysis also showed that SmCLl was present at approximately 
double the amount in female adult worms in comparison to males. It is estimated that fully 
mature male and female adult S. mansoni ingest 39,000 and 330,000 host red blood cells 
per hour respectively (Lawrence, 1973). Therefore, it would be expected that digestive 
enzymes involved in haemoglobin digestion would be overexpressed in female worms. 
However, such enzymes would be expected to be present in 8-10 times the amounts in 
females as opposed to males. It is possible that in males SmCLl may be involved in other 
functions besides haemoglobin digestion. Immunolocalisation experiments performed in 
this study have shown that the enzyme is also present in the tegument of both male and 
female worms as well as in the gastrodermal cells lining the gut (Fig. 2.9); Furthermore, 
the labelling in the tegument was much more intense in males than in females. The function 
of SmCLl in the tegument is not yet understood but it may play some role in surface 
membrane turnover as discussed later.
SmCL2 was present at approximately five times the amount in females in 
comparison to males. This was expected as the cDNA encoding for SmCL2 was originally 
isolated by subtractive hybridisation from a female-enriched cDNA library (Michel et a l, 
1995). Unlike SmCLl, SmCL2 is not thought to be involved in haemoglobin degradation 
but its localisation to regions related to the reproductive system of females (Michel et al., 
1995) may explain why the enzyme is preferentially expressed in females. SmCL2 is 
thought to aid the passage of oocytes, vitelline cells and eggs through the uterus by 
altering the viscosity of the fluid in the ducts of the female reroductive system (Michel et
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al., 1995). Such a function would require high levels of expression of SmCL2 in females, 
as the females produce huge numbers of eggs which need to be transported from the 
uterus to the female genital porus and eventually, to the exterior of the worm.
Both SmCLl and SmCL2 were also shown to be present in the excretory/secretory 
(ES) products of adult worms, suggesting that the enzymes are secreted by these worms. 
Only the mature enzymes were present in the ES products, suggesting that the proteinases 
are processed as they are trafficked through the secretory pathway, releasing the mature, 
active zymogen. High levels of cathepsin L-like activity has been found previously in the 
ES products of S. mansoni (Dalton et al., 1996a), and this is likely due to the presence of 
SmCLl and SmCL2. Michel et al. (1992) postulated that SmCL2 may be secreted due to 
its apparent presence in the ducts of the female, and, to a lesser extent, the male 
reproductive systems. The signal obtained on immunoblots suggests that there are low 
levels of SmCL2 present in the ES products in comparison to the very high levels found in 
extracts of female worms. It is possible that the presence of SmCL2 in the ES products is 
due to leakage of the enzyme from the genital porus, rather than any active secretion of 
the enzyme into the medium by schistosome cells.
In this study, SmCLl has been localised to the gastrodermal cells lining the gut 
lumen of adult schistosomes (Fig. 2.9) and the presence of the mature proteinase in the ES 
products strongly suggests that the enzyme is actively secreted into the gut lumen of the 
schistosome. As haemoglobin digestion occurs extracellularly in the gut lumen (Lawrence 
et al., 1973), this data strongly suggests that SmCLl plays a central role in haemoglobin 
catabolism by schistosomes (discussed in section 5.6).
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For a long time, the cathepsin B of schistosomes was thought to be central in the 
degradation of haemoglobin, and indeed, the schistosome cathepsin B was considered to 
be the ‘haemoglobinase’ (Linquist et a l,  1986; McKerrow and Doenhoff, 1988; Gotz and 
Klinkert, 1993). However, Dalton and co-workers demonstrated the presence of cathepsin 
L-like activity in extracts and ES products of S. mansoni, and showed that the specific 
activity of this enzyme(s) in these preparations was much higher than the cathepsin B-like 
proteinase(s) (Smith et a l,  1994; Dalton et al., 1996a). This cathepsin L-like activity in 
adult worm extracts was ostensibly overlooked in previous studies of haemoglobin 
digestion because only the cathepsin B peptide substrate Z-Arg-Arg-NHMec was 
employed in the analysis (Linquist et al., 1986; McKerrow and Doenhoff, 1988; Gotz and 
Klinkert, 1993). Furthermore, recent studies by Lipps et al. (1996) revealed that active, 
recombinant S. mansoni cathepsin B expressed in yeast does not show a marked 
preference towards haemoglobin as substrate, which led these authors to conclude that 
cathepsin B does not merit the term haemoglobinase. It is possible that in the earlier 
reports, cathepsin L-like activities was unknowingly co-purified with the cathepsin B-like 
activity since these enzymes are very similar in molecular size. Consequently, the cathepsin 
L-like activities may have contributed to the potent haemoglobinolytic activity observed in 
these preparations.
In this study, the haemoglobinolytic potential of ySmCLl was examined by 
incubating human haemoglobin with the purified proteinase at various pH values and 
analysing the reaction products on SDS-PAGE gels. ySmCLl exhibited a marked
5.6: SmCLl plays a role in degradation of host haemoglobin
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preference for haemoglobin, cleaving this substrate at more than one site based on the 
smeared appearance of the digested products on gels. In contrast to peptide substrates and 
gelatin where ySmCLl showed a pH optimum for activity of 6.5, the proteinase most 
efficiently cleaved haemoglobin at pH 4.5. Indeed, haemoglobin was not digested at pH 
5 .0 or above in these assays. This indicates that the denaturation of the haemoglobin by 
the acidic pH may be required before it can be digested by SmCLl. Since the physico­
chemical environment of the schistosome gut appears to be acidic (Brindley et al., 1997), 
haemoglobin may be denatured in such conditions, thereby exposing the peptide bonds and 
allowing proteinases to efficiently digest the protein.
Like schistosomes, malaria parasites also obtain their amino acid nutrients through 
the degradation of host haemoglobin. Degradation by malaria parasites takes place in a 
specialised food vacuole that has a pH optimum of approximately 5.0. Three 
endoproteinases present in this vacuole have been implicated to be involved in 
haemoglobin digestion in Plasmodium falciparum, the most common strain of malaria. 
Falcipain, a cathepsin L-like cysteine proteinase (Rosenthal et al., 1988; Rosenthal, 1995; 
Salas et al., 1995), and the aspartic proteinase plasmepsins I and II (Goldberg et al., 1991; 
Francis et al. 1994) are thought to act in an ordered pathway of haemoglobin catabolism. 
The exact order of this pathway is, as yet, uncertain, however, both plasmepsin I 
(Goldberg et al., 1991) and falcipain (Salas et al., 1995) have been shown to readily 
cleave native haemoglobin and both have been implicated to be involved in the initial 
cleavages of native haemoglobin. This initial cleavage is thought to cause the molecule to 
unravel and denature, exposing the molecule to further proteolysis by the other digestive 
enzymes. The proteinases implicated in haemoglobin digestion in schistosomes (Fig. 1.1)
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may operate in an ordered fashion similarly to that described for malaria, although no 
evidence of such a pathway has yet emerged. From this study it would appear that SmCLl 
cannot cleave native haemoglobin and is unlikely to be involved in initial cleavages of 
haemoglobin in such an ordered pathway. Another proteinase, such as cathepsin D, which 
has been implicated to be involved in haemoglobin digestion, may perform these initial 
cleavages. However, it would seem unlikely that protozoan and helminth parasites, which 
are not very highly evolved organisms, would have developed such complex pathways for 
degradation of host tissues. The unravelling and denaturation of haemoglobin may be 
achieved by simpler means such as exposure to the low pH environment of the gut, 
thereby allowing the proteinases to randomly degrade the molecule.
Many of the various proteinases implicated to be involved in the degradation of 
haemoglobin by schistosomes, including cathepsin B (Ruppel et al., 1985), cathepsin D 
(Bogitsh and Kirschner, 1986, 1987), cathepsin C (Bogitsh and Dresden, 1983) and 
schistosome legumain (Zhong et al., 1995), have been localised to the epithelium of the 
schistosome gut and/or the gastrodermal cells surrounding the gut. As haemoglobin 
degradation is an extracellular process in schistosomes (Lawrence, 1973), secretion of 
digestive proteinases into the gut epithelium is essential if they are to be involved in this 
process. In this study, immunolocalisation experiments were performed to determine the 
site of expression and/or activity of SmCLl within the adult schistosome. SmCLl was 
shown to be expressed in the gastrodermal cells, which is consistent with the results that 
demonstrated the presence of SmCLl in the ES products. Collectively, this data suggests 
that the enzyme is secreted into the gut epithelium of adult schistosomes.
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It is noteworthy that SmCLl is also located in the tegument of the adult worms. 
Other enzymes such as schistosome legumain (Zhong el al., 1995) and cathepsin D 
(Bogitsh and Kirschner, 1986, 1987) that are associated with the gut have also been 
located in the tegument. These enzymes may function in intracellular turnover or in 
membrane biogenesis, in the tegument of the worm. Indeed, it is especially interesting that 
schistosome legumain is expressed in the same tissues as SmCLl and cathepsin D, a 
finding which further supports its proposed role in the processing and activation of these 
enzymes.
To summarise, almost forty years after pioneering studies performed by Timms and 
Bueding (1959), which suggested that the catabolism of host haemoglobin by 
schistosomes is achieved by ‘the action of one or several proteolytic enzymes present in 
the alimentary canal of the worms’, the mechanism and components involved in this 
process are still not fully understood. Many proteinases are now implicated in this process 
(Fig 1.1; Dalton et al., 1995a; Brindley etal., 1997). The present results demonstrating 
the presence of SmCLl in the gastrodermal cells lining the schistosome gut and in the ES 
products, and its ability to digest human haemoglobin at acidic pH indicate that SmCLl 
plays some role in the progressive proteolysis of haemoglobin within the schistosome gut. 
This study, and ongoing studies on other putative haemoglobinases, would seem to 
support the early hypotheses of Timms and Bueding (1959).
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SmCLl and SmCL2 were functionally expressed in Saccharomyces cerevisiae and the 
secreted recombinant enzymes purified from the culture medium. The expression of the 
enzymes in their active form allowed for their biochemical characterisation. Both enzymes 
displayed biochemical characteristics typical of cathepsin L-like proteinases. However, 
recombinant SmCLl and SmCL2 displayed distinct differences in their specificities for 
synthetic peptide substrates. SmCLl favours substrates containing the following general 
m otif: aliphatic (P3)-aliphatic (P2)-positive or polar hydrophobic (Pi), whereas SmCL2 
may favour aliphatic (P3)-aromatic (P2)-positive (Pi). The enzymes also exhibited 
differences in their pH profiles of activity against Z-Phe-Arg-NHMec. SmCLl maintained 
high levels of activity over a wide pH range, peaking at pH 6.5. In contrast, SmCL2 was 
only active between pH 2.7 and 6.5.
These results, coupled with studies on the expression of SmCLl and SmCL2 in 
schistosomes would seem to suggest that these enzymes play quite different roles. Data 
presented in this study would seem to confirm the role of SmCLl in the degradation of 
host haemoglobin by these parasites. Previous studies performed by Michel et al. (1995) 
have implicated SmCL2 to play some role in reproduction, possibly in formation of egg­
shell precursor proteins or passage of eggs through the reproductive ducts.
Inhibition studies performed by Wasilewski et al. (1996) demonstrated that 
cysteine proteinase inhibitors blocked schistosome haemoglobin degradation in vitro and 
decreased worm burden and egg production in mouse models. These inhibitors were 
capable of inhibiting cathepsin L-like as well as cathepsin B-like proteinases. It is possible 
that the arrest in haemoglobin degradation observed by these authors was due to inhibiton
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of SmCLl, as well as cathepsin B which the authors originally proposed. As SmCL2 has 
been implicated in the production of eggs in female worms (Michel et al., 1995), the 
decrease in egg production observed by Wasilewski et al. (1996) may be due to inhibition 
of this enzyme.
If indeed SmCLl and SmCL2 have roles to play in nutrition and reproduction in 
schistosomes, the development of inhibitors targeting these enzymes could represent a 
very promising approach to new chemotherapy that may arrest both infection and egg- 
induced pathology associated with schistosomiasis.
5.7: Future prospects
While this and previous studies have gone some way towards characterising SmCLl and 
SmCL2, further studies are required to confirm their proposed biological roles. 
Ultrastructural immunolocalisation experiments are currently being performed in 
collaboration with Dr. Burton Bogitsch, Vanderbilt University, Nashville, Tennessee 
which may reveal the sub-cellular location of these proteinases and thereby give further 
insight into their functions. In particular, the role of SmCLl in the tegument is unclear. If 
SmCLl contributes to membrane turnover in the tegument, analysis of the ability of the 
recombinant proteinase to cleave structural proteins in the tegument, in addition to 
subcellular localisation studies, would go some way to answering this question.
Ongoing studies being performed in collaboration with Dr. Ross Brinkworth, 
Centre for Drug Design, University of Queensland, Australia, aim to identify specific 
substrates for SmCLl and SmCL2 by homology modelling and mapping the active sites of 
the proteinases. This analysis may identify substrates which are cleaved preferentially by
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one or both enzymes compared to their mammalian homologues. Molecular modelling 
may also allow determination of how the pro-region interacts with the active sites of 
SmCLl and SmCL2, or more specifically, what residues within the pro-regions bind into 
the active site pockets to cause inhibition of activity. This data may provide valuable clues 
for the rational design of peptide inhibitors which may have potential chemotherapeutic 
value.
Ultimately, however, the design of inhibitors which specifically bind into the active 
sites of these molecules may depend on determination of the crystal structure of the 
proteinases. This study describing the functional expression and purification of 
recombinant SmCLl and SmCL2 means that the possibility of crystallising these enzymes 
now exists. In order to perform such studies, the S. cerevisiae expression system and the 
purification scheme would need to be upscaled and optimised so as to produce enough 
protein to initiate crystallisation studies. Alternatively, other expression and purification 
systems could be examined.
As well as developing effective drugs, the successful eradication of 
schistosomiaisis would also involve an immunisation program designed to enhance host 
resistance to reinfection. No effective vaccine is as yet available, however, both SmCLl 
and SmCL2 represent molecular vaccine candidates as these enzymes would appear to be 
centrally involved in functions which are vital for the survival of the parasite. In particular, 
if SmCL2 has a central role to play in egg formation in female adult worms, immunisation 
with this molecule could prove very effective. Blocking egg formation would cause a 
break in the life cycle and, therefore, stop the transmission of the disease. Furthermore, the 
hosts inflammatory response to the eggs causes the tissue pathology associated with
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schistosomiasis (Mahmoud and Wahals, 1990) and immunisation with SmCL2 may go 
some way to reducing this pathology. Studies by Dalton et al. (1996a) demonstrated the 
induction of protective immunity in cattle against infection with F. hepatica by vaccination 
with cathepsin L proteinases. Future work would involve vaccination of mice with the 
recombinant SmCLl and SmCL2 molecules and subsequent challenge with S. mansoni to 
assess their efficacy as vaccine candidates against schistosomiasis.
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